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A B S T R A C T
Background
Cervical intra-epithelial neoplasia (CIN) typically occurs in young women of reproductive age. Although several studies have reported
the impact that cervical conservative treatment may have on obstetric outcomes, there is much less evidence for fertility and early
pregnancy outcomes.
Objectives
To assess the effect of cervical treatment for CIN (excisional or ablative) on fertility and early pregnancy outcomes.
Search methods
We searched in January 2015 the following databases: the Cochrane Gynaecological Cancer Specialised Register, Cochrane Central
Register of Controlled Trials (CENTRAL; The Cochrane Library, Issue 12, 2014), MEDLINE (up to November week 3, 2014) and
EMBASE (up to week 52, 2014).
Selection criteria
We included all studies reporting on fertility and early pregnancy outcomes (less than 24 weeks of gestation) in women with a history
of CIN treatment (excisional or ablative) as compared to women that had not received treatment.
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Data collection and analysis
Studies were classified according to the treatment method used and the fertility or early pregnancy endpoint. Pooled risk ratios (RR)
and 95% confidence intervals (CI) were calculated using a random-effects model and inter-study heterogeneity was assessed with I2.
Two review authors (MK, AM) independently assessed the eligibility of retrieved papers and risk of bias. The two review authors then
compared their results and any disagreements were resolved by discussion. If still unresolved, a third review author (MA) was involved
until consensus was reached.
Main results
Fifteen studies (2,223,592 participants - 25,008 treated and 2,198,584 untreated) that fulfilled the inclusion criteria for this review
were identified from the literature search. The meta-analysis demonstrated that treatment for CIN did not adversely affect the chances
of conception. The overall pregnancy rate was higher for treated (43%) versus untreated women (38%; RR 1.29, 95% CI 1.02 to 1.64;
4 studies, 38,050 participants, very low quality), although the inter-study heterogeneity was considerable (P < 0.01). The pregnancy
rates in treated and untreated women with an intention to conceive (88% versus 95%, RR 0.93, 95% CI 0.80 to 1.08; 2 studies, 70
participants, very low quality) and the number of women requiring more than 12 months to conceive (14% versus 9%, RR 1.45, 95%
CI 0.89 to 2.37; 3 studies, 1348 participants, very low quality) were no different. Although the total miscarriage rate (4.6% versus
2.8%, RR 1.04, 95% CI 0.90 to 1.21; 10 studies, 39,504 participants, low quality) and first trimester miscarriage rate (9.8% versus
8.4%, RR 1.16, 95% CI 0.80 to 1.69, 4 studies, 1103 participants, low quality) was similar for treated and untreated women, CIN
treatment was associated with an increased risk of second trimester miscarriage, (1.6% versus 0.4%, RR 2.60, 95% CI 1.45 to 4.67; 8
studies, 2,182,268 participants, low quality). The number of ectopic pregnancies (1.6% versus 0.8%, RR 1.89, 95% CI 1.50 to 2.39;
6 studies, 38,193 participants, low quality) and terminations (12.2% versus 7.4%, RR 1.71, 95% CI 1.31 to 2.22; 7 studies, 38,208
participants, low quality) were also higher in treated women.
The results should be interpreted with caution. The included studies were often small with heterogenous design. Most of these studies
were retrospective and of low or very low quality (GRADE assessment) and were therefore prone to bias. Subgroup analyses for the
individual treatment methods and comparison groups and analysis to stratify for the cone length was not possible.
Authors’ conclusions
Thismeta-analysis suggests that treatment for CINdoes not adversely affect fertility, although treatmentwas associatedwith an increased
risk of miscarriage in the second trimester. These results should be interpreted with caution as the included studies were non-randomised
and many were of low or very low quality and therefore at high risk of bias. Research should explore mechanisms that may explain the
increase in mid-trimester miscarriage risk and stratify this impact of treatment by the length of the cone and the treatment method
used.
P L A I N L A N G U A G E S U M M A R Y
Fertility and early pregnancy outcomes after treatment for cervical pre-cancer (cervical intra-epithelial neoplasia)
The issue
Preterm birth risk is higher after local treatment for precancer of the neck of the womb (cervix), yet there are only a few research studies
that have investigated the effect on fertility and early pregnancy outcomes following treatment.
The aim of the review
We aimed to assess whether treatment for this cancer - cervical intra-epithelial neoplasia (CIN) - adversely affects the chances of a
successful conception and pregnancy outcomes in the first and second trimesters (less than 24 weeks of gestation).
What are the main findings?
We included all studies that assessed fertility and early pregnancy outcomes in women who had local treatment of CIN versus untreated
women. We identified fifteen suitable studies.
Fertility outcomes
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The results suggest that local treatment of the cervix does not adversely affect the ability to conceive; in fact the overall pregnancy rate
was higher for treated women when compared to untreated women (43% versus 38%). There was no difference in the pregnancy rates
in women that intended to conceive (88% treated versus 95% untreated) or in the number of women requiring more than 12 months
to conceive (15% treated versus 9% untreated).
Early pregnancy outcomes
The rates of total (less than 24 weeks of gestation) and first trimester (less than 12 weeks of gestation) miscarriage were no different.
However, women after treatment had a significantly higher second trimester miscarriage rate (between 12 and 24 weeks of gestation)
compared to untreated controls (1.6% versus 0.4%). The rates of ectopic pregnancies and terminations of pregnancy were higher for
treated versus untreated women.
What is the quality of the evidence?
The results should be interpreted with caution as the included studies were small and of mixed design. Most of the studies were of low
quality and retrospective (looking at information recorded previously). Investigation of the effect of different treatments techniques
and of the size of the tissue removed (i.e. cone length) was not possible.
What are the conclusions?
The results suggest that treatment for CIN does not adversely affect the chances of a successful conception, although treatment is
associated with an increased risk of miscarriage in the second trimester. These conclusions should be interpreted with caution as the
quality of the included studies was low or very low. Future research should investigate the impact related to the extent of the treatment
and the treatment method used.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Fertility outcomes for cervical intraepithelial lesions
Patient or population: patients with cervical intraepithelial lesions
Setting: colposcopy clinic
Intervention: cervical treatment for CIN (excisional or ablative)
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
Number of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Untreated Cervical treatment for
CIN (excisional or abla-
tive)
Total pregnancy rate Study population RR 1.29
(1.02 to 1.64)
38050
(4 studies)
⊕©©©
very low1
Observational studies
only
1 study assessed as low
quality.
2 studies downgraded to
very low quality due to
study design (high risk
of publication bias) and
wide confidence intervals
11 study upgraded to
moderate quality due to
large study population
and magnitude of effect
382 per 1000 493 per 1000
(390 to 627)
Control population
368 per 1000 475 per 1000
(375 to 604)
Pregnancy rate in
women with intention to
conceive
Study population RR 0.93
(0.8 to 1.08)
70
(2 studies)
⊕©©©
very low2
Observational studies
only
2 studies assessed as
very low quality due to
study design (high risk
of publication bias) and
wide confidence intervals4
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946 per 1000 880 per 1000
(757 to 1000)
Control population
950 per 1000 883 per 1000
(760 to 1000)
Conception at > 12
months
Study population RR 1.45
(0.89 to 2.37)
1348
(3 studies)
⊕©©©
very low3
Observational studies
only
2 studies assessed as
low quality.
1 study downgraded to
very low quality due to
study design (high risk
of publication bias) and
wide confidence intervals
92 per 1000 117 per 1000
(62 to 222)
Control population
140 per 1000 178 per 1000
(94 to 336)
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; CIN: cervical intraepithelial neoplasia; RR: risk ratio;
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1Downgraded to ’very low’ due to very high heterogeneity (I2 88%).
2Downgraded to ’very low’ due to all included studies assessed to be at high risk of publication bias, cohorts being poorly representative
of the entire population and poor response rate to study questionnaire.
3 Downgraded to ’very low’ due to high heterogeneity (I2 63%).
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B A C K G R O U N D
Description of the condition
Cervical cancer remains the commonest gynaecological malig-
nancy worldwide. Over half a million new cases are diagnosed
each year around the world, with the vast majority occurring in
developing countries, where a woman’s risk of developing cervical
cancer by age 74 is 1.6%, compared to 0.9% in developed coun-
tries (Ferlay 2013).
The introduction of cervical screening programmes over the last
twenty years has resulted in a profound decrease in the incidence
and mortality from cervical cancer through early identification
and treatment of screen-detected pre-invasive lesions of the cervix,
known as cervical intraepithelial neoplasia (CIN; Arbyn 2009;
Quinn 1999). CIN lesions are pre-cancerous abnormalities in the
cells of the cervix (neck of the womb); if left untreated, cervical
cancer may develop. These lesions are asymptomatic and inter-
ventions to treat them in young women are usually offered only in
high-grade disease (CIN grade 2 or 3, also known as HSIL - high-
grade squamous intra-epithelial lesions; NHS Cervical Screening
Programme 2010). This is because cervical treatment has been cor-
related to adverse obstetric sequelae (Kyrgiou 2006), while many
of the low-grade lesions (also known as LSIL - low-grade squa-
mous intra-epithelial lesions) resolve spontaneously in young in-
dividuals (NHS Cervical Screening Programme 2010).
The average age of a woman diagnosed and treated for CIN is be-
tween 25 and 30 years of age, although itmay occur inwomen con-
siderably younger (NHS Cervical Screening Programme 2012).
As the pre-cancerous lesions typically occur in young women of
reproductive age, the impact of their treatment on the outcomes
of subsequent pregnancies has been an area of active research for
the past decade. Whilst it is paramount that effective treatment is
undertaken, it is also important that this treatment has minimal
adverse effects on future fertility and pregnancy outcomes for this
young female population.
Description of the intervention
Cold knife conisation (CKC), laser ablation (LA), laser conisation
(LC), cryotherapy (CT), cold coagulation (CC), radical diathermy
(RD), large loop excision of the transformation zone (LLETZ,
also known as loop electrosurgical excisional procedure (LEEP))
and needle excision of the transformation zone (NETZ, also know
as straight wire excision of the transformation zone (SWETZ);
Kitchener 1995; Prendiville 1989) are all conservative local meth-
ods of treatment for CIN, which attempt to remove or destroy
the transformation zone (TZ) of the cervix (the transition area
from squamous to columnar epithelium in which the abnormal
cells develop). These techniques use different surgical instruments
(i.e. knife, laser, loop or straight wire, coagulator probe) and en-
ergy sources (i.e. laser, diathermy, coagulation) to excise or ablate
a cone-shaped part of the cervix that contains the pre-cancerous
cells.
The characteristics of these techniques are well described. LLETZ,
LC and ablation are usually performed under local anaesthesia
in an outpatient setting, while CKC requires general anaesthe-
sia and hospitalisation. Theoretically, the excisional techniques
(CKC, LC, LLETZ) are superior over the destructive (LA, CC,
CT), as they allow a comprehensive histological evaluation of the
removed tissue and the whole TZ, with precise evaluation of ex-
cision margins. Ablative techniques destroy the TZ epithelium;
they preclude histological evaluation and demand accurate pre-
treatment biopsy at a separate visit. LLETZ is the most favoured
technique, by combining all the advantages of the excisional tech-
niques mentioned above together with a relatively shorter dura-
tion, low cost, good compliance, simplicity and easier learning
curve for practitioners (Kitchener 1995; Prendiville 1989).
A recent Cochrane review reported that all the treatment tech-
niques have low rates of surgical morbidity and all with the ex-
ception of CT have similar rates of pre-cancerous recurrence
(Martin-Hirsch 2013; Nuovo 2000) and post-treatment invasive
disease (Chew 1999; Paraskevaidis 1991; Soutter 1997).
How the intervention might work
Severalmeta-analyses (Arbyn2008;Kyrgiou 2006) and large retro-
spective linkage studies (Albrechtsen 2008; Noehr 2009) have pre-
viously reported that women with a history of an excisional tech-
nique (CKC, LLETZ and LC) have an increased risk of preterm
birth (less than 24 weeks of gestation), low-birth weight (less than
2,500 g), premature rupture of themembranes and perinatal mor-
tality in a subsequent pregnancy. It is, however, plausible that
the disease itself (CIN) and other confounders (such as smok-
ing, occult infections etc.) may contribute to that increased risk
(Bruinsma 2007; Castanon 2012; Kyrgiou 2012).
Although the impact that local treatment of the cervix has on
the obstetric sequelae has been extensively described, its effect on
the ability to conceive and early pregnancy outcomes has been
relatively under-reported (Hammond 1990; Paraskevaidis 2007).
Cervical treatment excises or ablates part of the endocervical canal
and, as a result, the mucus-secreting glands, which produce secre-
tions facilitating sperm penetration and conception. This has been
suggested to adversely affect the chances of a successful conception
(Kennedy 1993; Spracklen 2013; Suarez 2006). The loss of the
normal functional cervical structure and the healing process in the
regenerated crater after excision may also induce severe stenosis of
the cervical os that may further inhibit the sperm penetration and
conception (Luesley 1985; Suarez 2006).
The published evidence assessing the impact of cervical treatment
fertility are somewhat inconsistent. Two small case-series (Bigrigg
1994; Weber 1979) reported that cervical treatment did not pro-
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long the time required to conceive. A large retrospective popula-
tion-based cohort from Finland that included more than 35,000
women and a follow-up of over 250,000 women-years reported
no negative effect from treatment. Treated women actually had
more pregnancies and children when compared to the reference
untreated population, although data for the pregnancy rates in
those with the intention to conceive was not reported (Kalliala
2012). However, this study was followed by another large cohort
from the USA that resulted in contradictory results. Women who
were previously treated took longer to conceive than untreated
women without the disease, or women who attended colposcopy
but were not treated (time to conception more than 12 months
16.4% versus 8.4%, adjusted odds ratio (OR) 2.09, 95% CI 1.26
to 3.46) (Spracklen 2013).
A systematic review that focused mainly on obstetric outcomes
after cervical treatment previously reported on studies assessing the
impact of treatment on fertility (Kyrgiou 2006). A meta-analysis
on fertility outcomes was not possible due to the limited number
of published reports at the time.
It has also been suggested that cervical treatment may adversely
impact on early pregnancy outcomes. Although first-trimester
miscarriages are usually a result of fetal malformation and ab-
normal karyotype (Phillipp 2003), mid-trimester losses (second
trimester miscarriages) share common aetiopathogenic pathways
with pretermbirth related to cervical incompetence, inflammation
and damage of the host’s defence mechanisms (Kyrgiou 2015).
Why it is important to do this review
Authors who have assessed fertility outcomes have reached contra-
dictory conclusions based on data from rather small populations.
There are no randomised controlled trials (RCTs) that compare
fertility and early pregnancy outcomes in treated versus untreated
women with CIN. Due to the pre-malignant nature of the condi-
tion that is being treated, it is unlikely that one will ever be con-
ducted. The best level of evidence may therefore be drawn from a
systematic review and meta-analysis of cohort studies.
The impact that the treatment may have on conception and
childbearing causes anxiety and psychological morbidity to many
young women requiring local treatment of the cervix. Although
the impact that cervical treatmentmay have on obstetric outcomes
has been the subject of several large studies (Castanon 2014b;
Jakobsson 2007) andmeta-analyses (Arbyn 2008; Bruinsma 2011;
Kyrgiou 2006), the existing evidence on the early pregnancy and
fertility outcomes is limited, often contradictory and poorly doc-
umented.
A systematic review and meta-analysis focusing on fertility and
early pregnancy outcomes in women who have had a local treat-
ment of the cervix as compared to those who have not was clearly
overdue. This review critically appraises the existing literature
and quantifies the impact that these interventions may have on
women’s reproductive health. This data can help clinicians’ deci-
sionmaking and informpatients’ choice. It further allows the iden-
tification of a group at high-risk of mid-trimester loss. Although
the data analysed only relies on retrospective cohorts that may be
prone to bias, the results provide a comprehensive overview of the
published literature.
O B J E C T I V E S
To assess the effect of cervical treatment for CIN (excisional or
ablative) on fertility and early pregnancy outcomes.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included all studies reporting on fertility and early pregnancy
outcomes (less than 24weeks of gestation) inwomenwith a history
of CIN treatment as compared to women who did not received
treatment.
Studies were included irrespective of the type of untreated ref-
erence population. The comparison group could include: a) un-
treated women from the general population matched or not for
known risk factors and possible confounders; b) internal controls
with self-matching pregnancies for the same women before treat-
ment; c) women with CIN that attended colposcopy but did not
receive treatment. Given the non-randomised nature of the in-
cluded studies, the choice of comparison group may impact on
the risk estimate for each reported outcome and may introduce
bias by over-estimating the effect of treatment that may be partly
attributed to other confounders (Kyrgiou 2012).
We excluded studies that did not include an untreated reference
population. Studies that compared outcomes for treatments per-
formed during pregnancy were also excluded.
Types of participants
All women of reproductive potential (fertility outcomes) and all
women that had a pregnancy (early pregnancy outcomes) with or
without a previous conservative local treatment of the cervix for
CINwere eligible for inclusion.Womenwere included irrespective
of the grade of the lesion for both squamous and glandular intra-
epithelial neoplasia.
7Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Types of interventions
The interventions included any type of conservative local method
of treatment, either excisional (CKC, LLETZ/LEEP, LC, NETZ/
SWETZ) or ablative (LA, CT, CC, RD). In studies that reported
on the impact of several different treatment techniques, as com-
pared to untreated controls, we extracted the outcomes according
to specific treatment method, where possible. If the outcomes in
an individual study were not reported separately for each tech-
nique, we analysed the intervention under broader terms, i.e. ex-
cisional treatment not otherwise specified (NOS), ablative treat-
ment NOS and treatment NOS. The detailed information on the
exact treatment technique is not infrequently unavailable in na-
tional registries.
Types of outcome measures
Primary outcomes
Total pregnancy rates (fertility outcome).
Secondary outcomes
• Fertility outcomes:
◦ Pregnancy rates in women with an intention to
conceive in an unspecified period.
◦ Conception rates within a given period: 0 to 3 months
(m), 0 to 6 m, 0 to 9 m, 0 to 12 m, 0 to 24 m, > 12 m, > 36 m.
• Early pregnancy outcomes (less than 24 weeks of gestation):
◦ Total miscarriage rates (less than 24 weeks of
gestation).
◦ First trimester miscarriage rates (less than 12 weeks of
gestation).
◦ Second trimester miscarriage rates (between 12 and 24
weeks of gestation).
◦ Ectopic pregnancy rates.
◦ Molar (abnormal development of foetus and placenta)
pregnancy rates.
◦ Termination of pregnancy rates.
Search methods for identification of studies
We sought papers in all languages and carried out translations if
necessary. The literature searches started in 1948 and included
references published up to November 2014.
Electronic searches
See the Cochrane Gynaecological Cancer Groupmethods used in
reviews.
We searched the following electronic databases in January 2015:
• The Cochrane Gynaecological Cancer Specialised Register.
• Cochrane Central Register of Controlled Trials
(CENTRAL; The Cochrane Library, Issue 12, 2014).
• MEDLINE (1948 to November week 3, 2014).
• EMBASE (1980 to week 52, 2014).
The MEDLINE search strategy based on terms related to the re-
view topic is presented in Appendix 1. We used the ’related arti-
cles’ feature in MEDLINE to retrieve additional references. For
databases other than MEDLINE, we adapted the search strategy
accordingly. The full search strategies for EMBASE and CEN-
TRAL are attached in Appendix 2 and Appendix 3.
Searching other resources
We searched metaregister, Physicians Data
Query, www.controlled-trials.com/rct, www.clinicaltrials.gov and
www.cancer.gov/clinicaltrials for ongoing studies and contacted
the main investigators of any relevant ongoing trials for further
information.
We searched conference proceedings and abstracts through ZE-
TOC(http://zetoc.mimas.ac.uk) andWorldCatDissertations.We
also searched reports of conferences within the following sources:
• Annual Meeting of the British Society of Colposcopy and
Cervical Pathology.
• Annual Meeting of the International Federation of Cervical
Pathology and Colposcopy.
• Annual Meeting of European Federation of Colposcopy.
• Annual Meeding of the American Society of Colposcopy
and Cervical Pathology.
We checked the citation lists of included studies and contacted ex-
perts in the field, including directors of UK cancer and colposcopy
registries, to identify further reports of studies.
We included both published and unpublished studies that met the
inclusion criteria for the review.
Data collection and analysis
Selection of studies
We downloaded all titles and abstracts retrieved by electronic
searching into a database using the reference management soft-
ware, EndNote. We removed duplicates and two review authors
(MK, AM) independently examined the remaining references. Ti-
tles and abstracts retrieved from other sources were also added
to the EndNote database. Those studies which clearly did not
meet the inclusion criteria were excluded and copies of the full
text of potentially relevant references were obtained. Two review
authors (MK, AM) independently assessed the eligibility of re-
trieved papers. The two review authors then compared their results
and any disagreements were resolved by discussion. If still unre-
solved, a third review author (MA) was involved until consensus
was reached. Reasons for exclusion were documented.
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Data extraction and management
We classified the studies according to treatment modality (i.e.
CKC, LC, LLETZ, LA etc) and in groups of excisional or ablative
techniques.
We retrieved from each study the number of events in treated
and untreated women for each outcome of interest (fertility and
early pregnancy outcomes). We did not need to contact authors
of the included studies, as all the required data were provided in
the original reports.
We distinguished the different untreated reference populations
across studies: a) matched to the treated group for known risk
factors, b) self-matching/internal controls, i.e. the same women
before versus after treatment, c) women who attended colposcopy
with or without biopsy who did not undergo treatment. The
matching criteria applied for the selection of an untreated group
of women were also recorded (i.e. age, parity, smoking, socioeco-
nomic status, etc.).
For included studies, the following data were extracted:
• Author, year of publication, journal and language.
• Country.
• Setting in which the study was conducted.
• Inclusion and exclusion criteria.
• Study design, methodology.
• Study population:
◦ Total number enrolled and number included in each
group.
◦ Patient characteristics.
◦ Age.
◦ Grade of CIN.
◦ Parity.
◦ Single/multiple pregnancy.
◦ Smoking history.
◦ Socioeconomic status.
◦ Cone size/length.
◦ Control for confounding factors.
• Intervention details:
◦ Type of procedure used (excisional or ablative)
◦ Pprocedure used (excisional: CKC, LLETZ/LEEP, LC,
NETZ/SWETZ; ablative: LA, RD, CC, CT).
• Details of the untreated group: (a) general population
matched to the treated group for known risk factors, b) self-
matching/internal controls that compare outcomes of the same
women before and after CIN treatment, c) women who attended
colposcopy with or without biopsy who did not undergo
treatment.
• Risk of bias (Assessment of risk of bias in included studies).
• Outcomes reported in each study:
◦ Primary outcomes:
⋄ Total pregnancy rates in treated versus untreated
women.
◦ Secondary outcomes:
⋄ Fertility outcomes: pregnancy rates in women
with an intention to conceive; conception rates within a given
period: 0 to 3 months (m), 0 to 6 m, 0 to 9 m, 0 to 12 m, 0 to
24 m, more than 12 m, more than 36 m.
⋄ Early pregnancy outcomes (less than 24 weeks of
gestation): total miscarriage rates; first trimester miscarriage
rates; second trimester miscarriage rates; ectopic pregnancy rates;
molar pregnancy rates; termination of pregnancy rates.
◦ Additional outcome data:
⋄ Outcome definition.
⋄ Number of participants allocated to each group.
⋄ For each outcome of interest: number of
observed events and missing participants.
⋄ For dichotomous outcomes of interest: number
of observed events in each group (treated and untreated) and
missing participants.
Two review authors (MK, AM) independently extracted data. The
review authors resolved differences by discussion or by appeal to
a third review author (MA), if necessary.
Assessment of risk of bias in included studies
To assess the risk of bias in included RCTs, we planned to use the
Cochrane Collaboration’s tool, comprising assessments of the fol-
lowing study characteristics: sequence generation; allocation con-
cealment; blinding (of participants, healthcare providers and out-
come assessors); incomplete outcome data; selective reporting of
outcomes; other possible sources of bias (Higgins 2011).
As RCTs comparing women with CIN to non-treated are not fea-
sible or ethical due to the pre-malignant nature of the condition,
we anticipated that published evidence might rely only on ob-
servational cohort studies. As the comparison groups (treated for
CIN with a particular procedure versus non-treated) are non-ran-
domised, effects and effect sizes cannot be attributedwith certainty
to the treatment alone. The differences in the size of the treatment
effect across studies may be partly explained by the choice of con-
trol population, because women with CINmay have demographic
and behavioural characteristics or even background immunolog-
ical imbalances that place them at higher baseline risk of adverse
reproductive outcomes.
It should also be noted that all eligible comparison groups have ad-
vantages and limitations. A recent meta-analysis showed that the
use of historical external controls might produce inherent biases
that could inflate the contribution of cervical treatment to adverse
outcomes, even if the authors control for possible confounders
(such as age, parity, smoking etc; Bruinsma 2011). The use of
internal controls (pregnancies in the index woman before treat-
ment) is an attractive alternative approach, but even this might be
inadequate for confounders that are liable to change with time.
Women with mild precancerous lesions that do not warrant exci-
sion treatment probably provide the best, although still imperfect,
comparator. In contrast, those with high-grade disease who ne-
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glect treatment advice aimed at preventing cancer may have high
risk for confounders related to low socioeconomic class that may
influence fertility or pregnancy outcomes.
For non-randomised studies (NRS), the risk of bias was assessed
using the Newcastle-Ottawa score (Wells 2010), according to the
MOOSE checklist (Stroup 2000). This scoring system was devel-
oped for assessment of non-randomised cohort studies, based on
3 areas: a) cohort selection, b) comparability and c) assessment of
outcomes, to give a maximum score of 9 (highest quality). The
questions for the cohort selection assessed whether the exposed
and non-exposed cohorts were representative and appropriately
selected, how the exposure had been ascertained and whether there
was evidence that the outcome of interest was not present at the
start of the study. The comparability section assessed whether the
design or analysis ensured comparability of the exposed and un-
exposed cohorts. Finally the outcome section assessed how the
outcome was recorded and whether there was adequate follow-up.
Weused theGRADE (Grading ofRecommendations, Assessment,
Development and Evaluation) (GRADE Working Group 2004)
approach to assess the quality of evidence provided by the in-
cluded studies. We used GRADEpro (GRADE profiler) software
to generate ’Summary of findings’ tables to include an assessment
of all outcomes analysed. All studies were observational, thus were
assessed as low quality. We downgraded four studies to very low
quality due to risk of publication bias and wide confidence in-
tervals. We upgraded three studies due to large cohort size, plus
prospective study design in one case.
Measures of treatment effect
We calculated the risk ratio (RR) and 95% confidence intervals
(CI) for each reported outcome in the treated versus untreated
women for dichotomous outcomes. We used a random-effects
model to establish the RRs (Dersimonian 1986). In studies with
zero events in the treated or control group, or both we added 0.5
in each cell of the contingency table to allow calculation of RRs.
Dealing with missing data
We had intended to contact authors to obtain additional data
when only event rates were reported and the absolute number of
adverse obstetrical outcomes and total group sizes could not be
computed with sufficient precision from the data provided in the
original report. However, all the relevant data were contained in
the original reports.
Assessment of heterogeneity
We assessed inter-study heterogeneity with the Cochran Q test
(Cochran 1954), by visual inspection of forest plots, by estimation
of the percentage of heterogeneity between trials which cannot
be ascribed to sampling variation (I2 statistic; Higgins 2003) and
by a formal statistical test of the significance of the heterogeneity
(Deeks 2001). If there was evidence of substantial heterogeneity,
the possible reasons for this were investigated and reported.
Assessment of reporting biases
We planned to assess small study effects, i.e. whether RRs are
greater in studies with fewer participants, by visual exploration of
asymmetry in funnel plots and by two formal statistical tests: the
rank correlation test (Begg 1994) and the asymmetry regression
test (Egger 1997). Given the low number of studies included in
each of the meta-analyses, however, reporting bias could not be
formally assessed.
Data synthesis
We pooled the results of the studies in meta-analyses. For dichoto-
mous outcomes, we calculated RR and 95% CI.
In studies with multiple treatment groups, we proportionally di-
vided the ‘shared’ comparison group into the number of treatment
groups; we treated comparisons between each treatment group and
the split comparison group as independent comparisons.
We used random-effects models with inverse variance weighting
for all meta-analyses (Dersimonian 1986).
If data were not of suitable quality for meta-analysis, we reported
the results as a narrative in the text of the review.
Subgroup analysis and investigation of heterogeneity
The protocol of this Cochrane review foresaw to assess the impact
of co-variates on the effect size by performing subgroup meta-
analyses and meta-regression. Moreover, we were planning to ex-
plore the influence of the following study characteristics: calendar
period, continent, study type (prospective versus retrospective),
type of comparison group and cone size.
Due to the limited number of studies for each outcome, subgroup
analyses for the different comparison groups was not possible.
Furthemore, subgroup analyses for the cone size/length or the
interval from treatment to conception were also not feasible, as
these data were not available in the included studies.
We separated the effects of treatment by broad treatment types
(excisional NOS, ablative NOS or treatment NOS) and, if pos-
sible, by the exact treatment procedure, and compared them to
untreated controls.
Sensitivity analysis
Meta-analyses were repeated by restriction to studies where com-
parability of treated and non-treated groups was assured.
R E S U L T S
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Description of studies
The characteristics of the included and excluded studies and
the outcomes examined are described in the Characteristics of
included studies and Characteristics of excluded studies.
Results of the search
We retrieved 2027 citations from the literature search. Of those,
1816 were excluded based on the title and abstract; 211 were re-
trieved in full text for evaluation. We identified 15 studies that
fulfilled the inclusion criteria and 196 were excluded. No unpub-
lished studies could be identified. The details, including reasons
for exclusion, are present in the PRISMA flowchart (Moher 2009;
Figure 1).
Figure 1. PRISMA flowchart
Included studies
Fifteen studies assessed fertility and early pregnancy outcomes in
treated and non-treated women and were included in the analyses.
All, apart from one (Frega 2013), were retrospective cohort and
case-control studies. There were no RCTs.
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Three studies examined the impact of CKC on the studied out-
comes (Buller 1982; Larsson 1982; Weber 1979), six the impact
of LLETZ (Bigrigg 1994; Blomfield 1993; Cruickshank 1995;
Frega 2013; Tan 2004; Turlington 1996), one of LC (Sagot 1995)
and the remaining five examined multiple treatment techniques
(Albrechtsen 2008; Kallialla 2012; Sjoborg 2007; Spitzer 1995;
Spracklen 2013).
Some studies used as the comparison group untreated women
from the general population, matched for known risk factors lead-
ing to adverse reproductive outcomes (Bigrigg 1994; Blomfield
1993; Cruickshank 1995; Frega 2013; Tan 2004; Weber 1979).
Some studies included women attending colposcopy with or
without biopsy, who did not have treatment (Spracklen 2013;
Turlington 1996), others used internal controls (the outcomes of
the same women before treatment; Buller 1982; Larsson 1982;
Sagot 1995; Spitzer 1995; Weber 1979) whilst some performed a
logistic regression to control for possible confounders (Albrechtsen
2008; Kallialla 2012; Sjoborg 2007; Spracklen 2013). Specifically,
Spracklen 2013 included two comparison groups: women from
the general population and women who attended colposcopy but
were not treated.
The data were retrieved from hospital records, questionnaires and
national registries. The number of participants in the treated and
untreated groups ranged from 21 to 15,108 and 20 to 2,164,006,
respectively (Characteristics of included studies).
Excluded studies
One hundred and ninety-six studies were deemed unsuitable for
inclusion. Of those, 44 did not include an untreated group, 64 did
not include data on the fertility and early pregnancy complications,
18 described data for excisions performed during pregnancy, 30
were systematic reviews, eight were meta-analyses and eight were
letters with no relevant data (Characteristics of excluded studies).
Twenty four conference abstracts were identified and classified as
’studies awaiting classification’ due to a lack of sufficient detail en-
abling a decision regarding inclusion. We hand-searched the ref-
erence lists of the identified systematic reviews and meta-analyses
that assessed fertility or early pregnancy outcomes following CIN
treatment (Kyrgiou 2006). No additional studies were identified.
Risk of bias in included studies
The included studies were not randomised; they described retro-
spective cohorts of low quality and were therefore at high risk of
underlying bias. The majority of them were small (less than 500
cases and controls). The included studies varied with regard to
design, the data source, the study and comparison populations,
the reported outcomes, the length of follow-up and the matching
for possible confounders.
The comparison group used and the adjustment for possible
risk factors are important measures of study quality and risk of
bias. From the 10 studies that used external comparators, four
used logistic regression to adjust for possible confounders, as
described previously (Albrechtsen 2008; Kallialla 2012; Sjoborg
2007; Spracklen 2013). From the ones that matched for known
confounders, two matched for two factors (Bigrigg 1994; Weber
1979), and four matched for more than three factors (Blomfield
1993; Cruickshank 1995; Frega 2013; Sjoborg 2007). Four stud-
ies used internal controls (Buller 1982; Larsson 1982; Sagot 1995;
Spitzer 1995) and two of those matched for further risk factors
(Larsson 1982; Spitzer 1995). The comparison of treated women
to women who attended colposcopy but were not treated is likely
to offer the best control for possible confounders; only two small
studies included such a comparison (Spracklen 2013; Turlington
1996).
The two largest studies were population-based studies from Fin-
land (Kallialla 2012) and Norway (Albrechtsen 2008) and pro-
vided the best quality data on total pregnancy rates and sec-
ond trimestermiscarriages, respectively. Another large population-
based study from the USA (Spracklen 2013) reported on a clin-
ically informative outcome: the conception rate within a given
period. This study included two comparison groups: one of un-
treated women and another of women who attended colposcopy
but did not receive treatment. Although results from telephone
interviews are often at high risk of recall bias, this is an informa-
tive study of good quality, reporting on the most relevant fertil-
ity outcome. The study from Italy was prospective, describing a
relatively large cohort, but only reported on the total miscarriage
rate, which is a less useful clinical outcome (Frega 2013). Previous
smaller studies were less informative and of lower quality.
All included studies scored at least seven points on the New-
castle-Ottawa Scale. More specifically, six studies scored nine
points (Albrechtsen 2008; Blomfield 1993; Frega 2013; Kallialla
2012; Larsson 1982; Tan 2004), three studies scored eight points
(Sjoborg 2007; Spracklen 2013; Weber 1979) and the remaining
six scored seven points (Buller 1982; Bigrigg 1994; Cruickshank
1995; Sagot 1995; Sjoborg 2007; Turlington 1996). The exposed
group was truly or somewhat representative of the average women
in the community in all studies. All non-exposed cohorts were
drawn from the same community or included the same women be-
fore and after treatment. The exposure was ascertained by the hos-
pital or registry records in the majority of the studies; in only one
study this was done by computer-assisted structured interviews
(Spracklen 2013). All studies attempted to control for possible im-
balances amongst the compared population (comparability of the
groups) bymatching (Bigrigg 1994; Blomfield 1993; Cruickshank
1995; Frega 2013; Tan 2004; Weber 1979), regression analysis
for known risk factors (confounders; Albrechtsen 2008; Kallialla
2012; Sjoborg 2007; Spracklen2013), self-matching (Buller 1982;
Larsson 1982; Sagot 1995; Spitzer 1995; Weber 1979) or using as
comparators women who attended colposcopy but did not receive
treatment (Spracklen 2013; Turlington 1996). The majority used
record linkage for the assessment of the outcome, although five
relied on self-reporting (Bigrigg 1994; Cruickshank 1995; Spitzer
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1995; Spracklen 2013; Turlington 1996). All studies had long fol-
low-up and demonstrated that the outcome was not present at the
start of the study. In six studies, most subjects were accounted for
(adequacy of follow-up; Albrechtsen 2008; Blomfield 1993; Frega
2013; Kallialla 2012; Larsson 1982;Weber 1979), while in eight a
substantial proportion of the subjects (>20%) were not accounted
for, because these women did not respond to the questionnaire,
did not give consent or were lost to follow-up and data could not
be retrieved (Buller 1982; Bigrigg 1994; Cruickshank 1995; Sagot
1995; Sjoborg 2007; Spitzer 1995; Tan 2004; Turlington 1996).
A more detailed assessment is included in Appendix 4.
A description of the quality of the evidence is provided based on
the GRADE assessment for the fertility (Summary of findings for
the main comparison) and early pregnancy outcomes (Summary
of findings 2). As RCTs allocating women with CIN to non-treat-
ment cannot be performed due to the pre-malignant nature of
the condition, the only available evidence relies on observational
cohort studies. The included retrospective cohort studies are de-
scribed as being of low or very low quality, as these are non-ran-
domised (Quality of the evidence). We used unadjusted data for
the analyses. As most of the included studies were at low risk of
bias and the adjusted analysis for the two largest studies reported
similar results to the unadjusted one (Albrechtsen 2008; Kallialla
2012), it is unlikely that this has introduced bias.
Incomplete outcome data
All studies except for Frega 2013 described retrospective cohorts.
The studies that used hospital records or national registries as their
information source did not provide informationonmissing patient
or outcome data and their risk of attrition bias was assessed to be
low (Albrechtsen 2008; Blomfield 1993; Kallialla 2012; Larsson
1982). Frega 2013 reported that 18 women (3.7%) were lost to
follow-up and the risk of incomplete data was therefore low. In
one study that used data drawn from interviews, there was no
documentation of the response rate and the risk of attrition bias
was determined to be unclear (Weber 1979). Studies that used
questionnaires or required retrospective consent from patients for
data use had largely high proportions of non-responders and their
risk of incomplete outcome data was deemed to be high (Bigrigg
1994; Buller 1982; Cruickshank 1995; Sagot 1995; Sjoborg 2007;
Spitzer 1995; Spracklen 2013; Tan 2004; Turlington 1996).
Selective reporting
The vast majority of the studies were retrospective cohort. Only
Frega 2013 followed up patients prospectively.None of the studies
had previously published a protocol and therefore the assessment
of possible reporting bias in each one of the individual studies was
difficult. There was no reason to suspect any selective reporting
of patients. However, the collected data were derived from reg-
istries, clinic data sets, telephone contacts and mailed question-
naires and this may present risks of selective reporting by patients
or researchers.
Other potential sources of bias
There were no other obvious sources of bias in most of the pub-
lished reports (Blomfield 1993; Buller 1982; Frega 2013; Kallialla
2012; Larsson 1982; Sagot 1995; Sjoborg 2007; Tan 2004). How-
ever, some retrospective cohorts reporting on fertility outcomes
collected data through questionnaires and interviews. More specif-
ically, six studies sourced information from patient telephone in-
terviews or mail questionnaires (Bigrigg 1994; Cruickshank 1995;
Spitzer 1995; Spracklen 2013; Turlington 1996; Weber 1979).
This study design may not provide a good cross-section of patients
and may be subject to a greater degree of recall bias (Bigrigg 1994;
Cruickshank 1995; Spitzer 1995; Spracklen 2013; Turlington
1996; Weber 1979) and misclassification bias (Albrechtsen 2008;
Bigrigg 1994; Cruickshank 1995; Spitzer 1995; Spracklen 2013;
Turlington 1996; Weber 1979) when compared to studies obtain-
ing information from hospital records (Blomfield 1993; Buller
1982; Larsson 1982; Sagot 1995; Tan 2004) or national registries
(Albrechtsen 2008; Kallialla 2012; Sjoborg 2007).
Effects of interventions
See: Summary of findings for the main comparison Fertility
outcomes for cervical intraepithelial lesions;Summary of findings
2 Early pregnancy outcomes for cervical intraepithelial lesions
Fertility outcomes
The results of the individual studies on the overall pregnancy rate
varied. Two studies did not report any significant differences be-
tween groups (Bigrigg 1994; Turlington 1996), while the remain-
ing two described significantly higher overall pregnancy rates for
the treated population (Bigrigg 1994; Spitzer 1995). Specifically,
Spitzer 1995 reported that women treated with LC or LA had high
pregnancy rates compared to untreated women (277/433; 64%
versus 177/433; 40.9%; RR1.56, 95%CI 1.37 to 1.79). Similarly,
Kallialla 2012 reported higher pregnancy rates for treated (CKC,
LLETZ, LC, LA or CT) versus untreated women (2578/6179;
41.7% versus 11,642/30,463; 38.2%; RR 1.09, 95% CI 1.06 to
1.13). The pooled analysis for the overall pregnancy rate assessed in
four studies was higher for treated versus untreated women (43%
versus 38%; RR 1.29, 95% CI 1.02 to 1.64, 4 studies, 38,050
participants; Analysis 1.1; Figure 2), although the heterogeneity
of the studies was considerable (I2 88%, P value < 0.00001, very
low quality evidence; Bigrigg 1994; Kallialla 2012; Spitzer 1995;
Turlington 1996).
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Figure 2. Forest plot of comparison: 1 Fertility outcomes, outcome: 1.1 Total pregnancy rates.
The pregnancy rate in women with an intention to conceive was
assessed in two small studies (Turlington 1996; Weber 1979) and
was nodifferent for treated compared tountreatedwomen in either
study. The pooled meta-analysis also confirmed that there were
no significant differences between treated and untreated women
(87.9% versus 94.6%; RR 0.93, 95% CI 0.80 to 1.08, 2 studies,
70 participants, I2 0%, P value = 0.77, very low quality evidence).
Both studies were at high risk of publication bias(Analysis 1.2).
The conception rate within a given period was described in three
small studies (Bigrigg 1994; Spracklen 2013; Weber 1979). Two
studies reported non-significant differences (Bigrigg 1994; Weber
1979), while the third suggested that the proportion of women
who required more than 12 months to conceive was significantly
higher for treated (all methods, not specified) versus all untreated
women (25/152; 16.4% versus 86/1021; 8.4%; RR 1.95, 95%
CI 1.29 to 2.95) or versus non-treated women attending for col-
poscopy (13/151; 8.6%; RR1.91, 95%CI 1.02 to 3.59; Spracklen
2013).
Themeta-analysis suggested that treatment did not adversely affect
the proportion of women who required more than 12 months to
conceive as compared to untreated controls (14.7% versus 9.2%,
RR1.45, 95%CI 0.89 to 2.37, P value = 0.14, 3 studies, 1348 par-
ticipants, I2 46%, very low quality evidence; Analysis 1.8; Analysis
1.9) or as compared to women attending colposcopy without re-
ceiving treatment (16.4% versus 8.6%, RR 1.88, 95% CI 0.99 to
3.55, 1 study, 303 participants, I2 0%, P value = 0.88; Analysis
1.11; Analysis 1.12; Figure 3). The proportion of women who
required more than 12 months to conceive was also no different
for women that had colposcopy as compared to women without
CIN (8.6% versus 8.4%, RR 1.02, 95% CI 0.59 to 1.79, 1 study,
1172 participants, I2 not estimable (NE), P value NE; Analysis
1.10). This comparison demonstrated moderate heterogeneity (I
2 46%). The remainder of the intervals to conception that were
assessed were also not significantly affected:
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Figure 3. Forest plot of comparison: 1 Fertility outcomes, outcome: 1.9 Conception >12 months (treatment
versus no treatment).
• Conception within 0 to 3 months: 49.5% versus 54.9%,
RR 0.89, 95% CI 0.67 to 1.19, 2 studies, 175 participants, I2
0%, P value = 0.58 (Analysis 1.3);
• Conception within 0 to 6 months: 78.5% versus 75.6%,
RR 1.03, 95% CI 0.89 to 1.19, 2 studies, 175 participants, I2
0%, P value = 0.97 (Analysis 1.4);
• Conception 0 to 9 months: 66.7% versus 65.0%, RR 1.03,
95% CI 0.66 to 1.59, 1 study, 41 participants, I2 NE, P value
NE (Analysis 1.5);
• Conception within 0 to12 months: 87.1% versus 84.1%,
RR 1.04, 95% CI 0.94 to 1.16, 2 studies, 175 participants, I2
0%, P value = 0.62 (Analysis 1.6);
• Conception within 0 to 24 months: 85.7% versus 90.0%,
RR 0.95, 95% CI 0.76 to 1.20, 1 study, 41 participants, I2 NE,
P value NE (Analysis 1.7);
• Conception within more than 36 months: 5.5% versus
8.0%, RR 0.69, 95% CI 0.19 to 2.45, 1 study, 134 participants,
I2 NE, P value NE (Analysis 1.13).
Early pregnancy outcomes
Early pregnancy outcomeswere assessed in 14 studies (Albrechtsen
2008; Bigrigg 1994; Blomfield 1993; Buller 1982; Cruickshank
1995; Frega 2013; Kallialla 2012; Larsson 1982; Sagot 1995;
Sjoborg 2007; Spitzer 1995; Tan 2004; Turlington 1996; Weber
1979).
All the studies that reported on the overall miscarriage rate sug-
gested that there was no difference between treated and untreated
populations (Bigrigg 1994; Buller 1982; Frega 2013; Kalliala
2012; Larsson 1982; Sagot 1995; Tan 2004; Turlington 1996;
Weber 1979), apart from one (Spitzer 1995). Spitzer 1995 re-
ported a protective effect for treated women as compared to un-
treated controls (11.4% versus 18.6%; RR 0.60, 95% CI 0.38 to
0.94, P value = 0.03). The pooled analysis for the total miscarriage
rate between treated and untreated women demonstrated no sig-
nificant difference (4.6% versus 2.8%, RR 1.04, 95% CI 0.90 to
1.21, 10 studies, 39504 participants, I2 9%, P value = 0.36, low
quality evidence; Analysis 2.1; Analysis 2.2; Figure 4) for any of
the methods assessed.
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Figure 4. Forest plot of comparison: 2 Early pregnancy outcomes, outcome: 2.2 Miscarriage rates
(treatment versus no treatment).
Four studies reported on first trimester miscarriage rates sepa-
rately (Buller 1982; Larsson 1982; Sagot 1995;Weber 1979); there
were no significant differences in any of the included studies. The
pooled meta-analysis for first trimester miscarriage rate did not
demonstrate a significant difference between treated and untreated
women (9.8% versus 8.4%, RR 1.16, 95% CI 0.80 to 1.69, 4
studies, 1103 participants; I2 0%, P value = 0.97, low quality ev-
idence; Analysis 2.3; Figure 5).
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Figure 5. Forest plot of comparison: 2 Early pregnancy outcomes, outcome: 2.3 1st trimester Miscarriage
rates (treatment versus no treatment).
Eight studies reported on second trimester miscarriage rates
(Albrechtsen 2008; Blomfield 1993; Buller 1982; Cruickshank
1995; Larsson 1982; Sagot 1995; Sjoborg 2007; Weber 1979).
Seven did not report significant differences, whilst one with a
large sample size (Albrechtsen 2008) demonstrated that treated
women had a higher second trimester miscarriage rate compared
to untreated women (226/15,108; 1.5% versus 8501/2,164,006;
0.4%; RR 3.81, 95% CI 3.34 to 4.34) or internal controls (209/
57136; 0.4%; RR 4.09, 95% CI 3.39 to 4.93). In the meta-anal-
ysis, we found that cervical treatment significantly increased the
risk of second trimester miscarriage. This outcome was assessed
in eight studies and 16,558 treated women. The rate was higher
for treated versus untreated women (1.6% versus 0.4%; RR 2.60,
95%CI 1.45 to 4.67, 8 studies, 2,182,268 participants, I2 41%, P
value = 0.12, low quality evidence; Figure 6, Analysis 2.4). There
was moderate inter-study heterogeneity. These results were largely
dominated by one large study from Norway that did not control
for smoking (Albrechtsen 2008). A sensitivity analysis with the
exclusion of this study revealed a similar direction, but smaller
magnitude, of the effect size (RR 1.78, 95% CI 0.98 to 3.20).
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Figure 6. Forest plot of comparison: 2 Early pregnancy outcomes, outcome: 2.4 2nd trimester miscarriage
rates (treatment versus no treatment).
The rate of ectopic pregnancy was also higher for treated com-
pared to untreated women (1.6% versus 0.8%; RR 1.89, 95% CI
1.50 to 2.39, 6 studies, 38,193 participants, I2 0%, P value = 0.44,
low quality evidence; Analysis 2.5; Analysis 2.6), while the molar
pregnancy rate did not differ ( Analysis 2.7). The termination of
pregnancy rate was higher in women with a history of treatment
compared to untreated controls (12.2% versus 7.4%) with mod-
erate heterogeneity (RR 1.71, 95% CI 1.31 to 2.22, 7 studies,
38,208 participants, I2 41%, P value = 01.0, low quality evidence;
Analysis 2.8; Analysis 2.9).
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Early pregnancy outcomes for cervical intraepithelial lesions
Patient or population: patients with cervical intraepithelial lesions
Settings: colposcopy clinics
Intervention: cervical treatment for CIN (excisional or ablative)
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
Number of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Untreated Cervical treatment for
CIN (excisional or abla-
tive)
Miscarriage rates Study population RR 1.04
(0.9 to 1.21)
39504
(10 studies)
⊕⊕©©
low1
Observational studies
only
5 studies assessed as
low quality.
3 studies downgraded to
very low quality due to
study design (high risk
of publication bias) and
wide confidence intervals
1 study upgraded to
moderate quality due to
large study population
and magnitude of effect
1s tudy upgraded to mod-
erate quality due to
prospective follow up of
large study population
and magnitude of effect
28 per 1000 29 per 1000
(25 to 34)
Control population
109 per 1000 113 per 1000
(98 to 132)
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1st trimester miscar-
riage rates
Study population RR 1.16
(0.8 to 1.69)
1103
(4 studies)
⊕⊕©©
low2
Observational studies
only
3 studies assessed as
low quality.
1 study downgraded to
very low quality due to
study design (high risk
of publication bias) and
wide confidence intervals
84 per 1000 97 per 1000
(67 to 142)
Control population
83 per 1000 96 per 1000
(66 to 140)
2nd trimester miscar-
riage rates
Study population RR 2.6
(1.45 to 4.67)
2182268
(8 studies)
⊕⊕©©
low3
Observational studies
only
5 studies assessed as
low quality.
2 studies downgraded to
very low quality due to
study design (high risk
of publication bias) and
wide confidence intervals
1 study upgraded to
moderate quality due to
large study population
and magnitude of effect
4 per 1000 10 per 1000
(6 to 18)
Control population
11 per 1000 29 per 1000
(16 to 51)
Ectopic pregnancy Study population RR 1.89
(1.5 to 2.39)
38193
(6 studies)
⊕⊕©©
low2
Observational studies
only
4 studies assessed as
low quality.
1 study downgraded to
very low quality due to
study design (high risk
of publication bias) and
wide confidence intervals
1 study upgraded to
moderate quality due to
large study population
and magnitude of effect2
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8 per 1000 14 per 1000
(11 to 18)
Control population
13 per 1000 25 per 1000
(19 to 31)
TOP rates Study population RR 1.71
(1.31 to 2.22)
38208
(7 studies)
⊕⊕©©
low3
Observational studies
only
4 studies assessed as
low quality.
2 studies downgraded to
very low quality due to
study design (high risk
of publication bias) and
wide confidence intervals
1 study upgraded to
moderate quality due to
large study population
and magnitude of effect
74 per 1000 127 per 1000
(97 to 165)
Control population
109 per 1000 186 per 1000
(143 to 242)
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; CIN: cervical intraepithelial neoplasia; RR: Risk ratio; TOP: termination of pregnancy
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1Included three very low quality studies being poorly representative of the intended study population with wide confidence intervals
and poor response rates to study questionnaires. Due to the small cohorts and good quality of the remaining included observational
studies, with a large cumulative study population, however, the authors concluded that this was unlikely to significantly bias the
results. In combination with the low overall heterogeneity of the analysis (I2 9%) the quality of evidence was maintained as low.
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2Included one very low quality study being poorly representative of the intended study population with wide confidence intervals,
however due to the small cohort, the authors concluded this was unlikely to significantly bias results. In combination with the low overall
heterogeneity of the analysis (I2 0%) the quality of evidence was maintained as low.
3Included two very low quality studies being poorly representative of the intended study population with wide confidence intervals
and poor response rates to study questionnaires, however due to the small cohorts and good quality of the remaining included
observational studies, with a large cumulative study population the authors concluded that this was unlikely to significantly bias the
results. Heterogeneity was intermediate, however the authors concluded this was unlikely to significantly bias results, therefore quality
of evidence was maintained as low.
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D I S C U S S I O N
Summary of main results
This systematic review and meta-analysis suggests that local con-
servative cervical treatment for CIN does not adversely affect fer-
tility outcomes. Pregnancy rates for treated women with an inten-
tion to conceive were comparable and the overall pregnancy rate
was higher as compared to untreated controls. However, hetero-
geneity across studies was considerable. The higher pregnancy rate
noted in the treated population may be explained by behavioural
characteristics in women with CIN (Kallialla 2012), possibly af-
fected by their increased anxiety with regard to their future fertil-
ity. The conception rate within a given post-treatment period did
not differ for treated and untreated women. There was a sugges-
tion that treated women took longer to conceive, but the number
of studies was small and the difference was not significant. Al-
though these findings raise the question as to whether treatment
prolongs the time to conception, the results may also be explained
by clinicians’ recommendations and patients’ preference to avoid
conception during the early post-operative period or until the first
follow-up assessment confirms the absence of residual disease.
The meta-analysis also suggested that conservative cervical treat-
ment for CIN may increase the risk of second trimester miscar-
riage. The results of the analysis onmid-trimester losses were dom-
inated by one large study (Albrechtsen 2008). This study did not
control for smoking and did not provide data for the individual
treatment techniques (knife, laser, LLETZ). The results of this
study were consistent with the remaining studies, and its exclusion
from the analysis did not change the direction of the effect. The
total and first trimester miscarriage rates were similar for treated
and untreated populations. The higher number of ectopic preg-
nancies and terminations in the treated population possibly re-
flects the characteristics of women with CIN, who are known to
be at a higher risk of sexually transmitted disease and unplanned
pregnancies (Kallialla 2012). This also highlights the limitations
of cohort studies, since the groups are not identical for other risk
factors likely to affect pregnancy outcomes.
The results of this review should be interpretedwith caution, as the
included studies were often retrospective, at high risk of recall bias
and with inadequate adjustment for possible confounders. The
analysis included studies with different designs, using comparisons
between and among women and mixed matching.
Overall completeness and applicability of
evidence
The choice of comparison groupmay substantially affect the result
of the analysis. Six studies matched for known confounders, three
adjusted for these in a regression analysis, five used comparisons of
the same women before and after treatment and only two used as
comparators women who attended colposcopy, had a biopsy, but
were not treated. The use of untreated controls without the CIN
may not account for occult confounders and may over-inflate the
effect of treatment (Bruinsma 2011; Kyrgiou 2012). A sensitivity
analysis that excluded the studies that used internal controls and
another that excluded old and/or poor quality studies did not
change the direction or the magnitude of the effect of the meta-
analysis. It was not possible to carry out subgroup analyses for
the comparison groups separately, due to the limited number of
studies in each group.
We analysed the results for the individual treatment techniques
separately for excision and ablation, and for all the techniques
jointly. The numbers of studies was small and the analyses of
the individual techniques did not have sufficient sample sizes to
support definite conclusions.
Analyses that would stratify according to the length of the cone
or parity were also not feasible, as these data were not reported by
the individual studies. It is likely that the risk of second trimester
miscarriage increases with increasing cone length or/and cervi-
cal proportion removed, similar to the effect seen for the risk of
preterm birth (Castanon 2014b; Kyrgiou 2012; Kyrgiou 2015;
Khalid 2012). The inability to adjust for the cone lengthmaymask
the true effect that deep cervical treatments may have on fertility
and may, conversely, over-inflate the risk that small treatments (<
10 mm in cone length) may have on the risk of mid-trimester loss.
Furthermore, an analysis of the second trimester miscarriage risk
or the ability to conceive stratified by the length of the interval
from treatment to pregnancy, or first attempt to conceive, was
not possible, as these data were not reported and could not be
extrapolated from any of the included studies. It is likely that some
women were advised by their clinicians to delay conception for
a few months post-treatment. A large population-based Finnish
cohort recently documented that the interval between treatment
and pregnancy does not impact on the risk of preterm birth (
Heinonen 2013). Assuming that themechanism formid-trimester
loss and preterm birth after cervical treatment is common, this
may also be the case for second trimester miscarriages.
Quality of the evidence
The included studies were heterogeneous in their design, compar-
ison group and outcomes. The number of studies and the study
size were small for many of the reported outcomes and the out-
comes of interest were difficult to objectively measure. Although
the inter-study heterogeneity was non-significant (apart from the
analysis of the total pregnancy rates), the number of studies was
small and the effect of the meta-analysis could be affected by the
addition of one large study. The sensitivity analysis that excluded
some of the largest studies did not change the results.
The quality of the evidence based on the GRADE assessment
was very low for the fertility outcomes (Summary of findings
for the main comparison) and low for all early pregnancy anal-
yses (Summary of findings 2). All of the included studies de-
scribed retrospective non-randomised cohorts; there was only one
prospective study (Frega 2013). Two of the observational cohort
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studies were population-based studies from Finland and Norway
(Albrechtsen 2008; Kallialla 2012) with big populations and large
magnitudes of effect and could be upgraded to moderate quality.
Some other studies had limitations in the design with high risk of
bias: theywere small with a study group that was not representative
of the whole population, had a low response rate to questionnaires
and had wide confidence intervals; these were downgraded to very
low quality (Bigrigg 1994; Cruickshank 1995; Turlington 1996;
Weber 1979).
Potential biases in the review process
All the included studies, apart from one (Frega 2013), described
retrospective cohorts that are prone to bias. As the evidence is not
based on RCTs, this analysis demonstrates an association but not
necessarily a causative relationship.
The data were derived from self-reports, clinic data sets, telephone
contacts, postal questionnaires or national registries and may rep-
resent incomplete and selected data. Early pregnancy outcomes
(before the age of viability) are less well reported than outcomes in
the third trimester. The level of over-reporting or under-reporting
may be different for treated and untreated women and the impact
that this may have is difficult to assess. Reporting may be better in
the treated group owing to easier access to gynaecological services,
or it could be lower in women with CIN, who often belong to
lower socioeconomic classes that are likely to be less compliant
with recommended medical care. It is also often difficult to accu-
rately assess fertility end-points, as the causes of subfertility may
vary substantially (i.e. partner’s fertility, tubal factor, age, ovarian
reserve, lifestyle) and elimination of all confounders may be im-
possible.
Given the non-randomised nature of the included studies, the
choice of comparison group may impact on the risk estimate for
each reported outcome (Kyrgiou 2012). Baseline imbalances in the
compared groups may substantially impact on the results. For ex-
ample, the lack of control for smoking is likely to introduce bias, as
smoking has been correlated with adverse reproductive outcomes.
A meta-analysis on the impact of cervical treatment on preterm
birth reported that studies using external comparators may over-
inflate the effect caused by treatment (Bruinsma 2011). This effect
is less pronounced for studies using internal controls, while those
using women with CIN but no treatment as a comparison group
are less likely to report an effect size largely affected by confounders
(Bruinsma 2011). There were only two studies in this meta-anal-
ysis that used women who had colposcopy and biopsy, but no
treatment as comparators (Spracklen 2013; Turlington 1996), and
they reported on different outcomes.
Many of the studies relied on data collected from structured inter-
views and mailed questionnaires with low response rates, at high
risk of incomplete outcome data (attrition bias). These studies
were also at risk of misclassification and recall bias.
We only included cohorts comparing treated women with un-
treated populations. As treatment is offered on the basis of a
precancerous disease, randomised studies are unlikely to be con-
ducted. Randomised studies comparing different techniques with
regard to reproductive outcomes were not found and may never be
conducted. Although the comparisons of treated versus untreated
women are prone to bias, this analysis provides the best possible
level of evidence to date, despite limitations.
We used for the analyses unadjusted data and this may have in-
troduced bias. The adjusted analysis for the two largest studies
(Albrechtsen 2008; Kallialla 2012) had similar results to the un-
adjusted one and therefore it is unlikely that adjustment would
alter the results of the meta-analysis.
In order to minimise bias whilst undertaking the review, the re-
trieved citations and the extracted data were independently re-
viewed by two authors (MK and AM). There were no discrepan-
cies in the included studies; some minor discrepancies in the data
extraction were resolved with discussion and the involvement of a
third reviewer (MA) when necessary.
Agreements and disagreements with other
studies or reviews
Treatment of CIN has been associated with an increased risk of ad-
verse obstetric sequelae and preterm birth in subsequent pregnan-
cies (Arbyn 2008; Bruinsma 2011; Kyrgiou 2006; Kyrgiou 2012;
Jakobsson 2007). More recent data suggests that CIN itself, or
confounders inwomen that have the disease,may partly contribute
to that risk (Bruinsma 2011; Castanon 2012). Increasing evidence
also suggests that the size (length) of the cone influences the fre-
quency and severity of premature birth (Arbyn 2014; Castanon
2014b; Founta 2010; Khalid 2012; Kyrgiou 2012; Noehr 2009).
A systematic review that focused mainly on obstetric outcomes
after cervical treatment also reported on studies assessing the im-
pact of treatment on fertility (Kyrgiou 2006). A meta-analysis on
fertility outcomes was not possible due to the limited number of
published reports at the time. Assessment of the individual studies
in this review did not suggest any impact of treatment on fertil-
ity. No systematic review and meta-analysis reported on the risk
of second trimester miscarriage. The results are consistent with a
previously published version of this review (Kyrgiou 2014).
The results are also consistent with large population-based studies
included in the review (Albrechtsen 2008; Kallialla 2012).
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
This meta-analysis suggests that treatment for CIN is unlikely to
have an adverse effect on fertility, although treatment was associ-
ated with an increased risk of miscarriage in the second trimester.
These results should be interpreted with caution, as the included
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studies were non-randomised andmanywere of low/very lowqual-
ity and at high risk of bias. Although we did demonstrate an asso-
ciation between treatment and mid-trimester miscarriage, we did
not prove causality.
The risk of second trimester miscarriages for less aggressive local
treatments and small cone length (i.e. a small LLETZ) and con-
versely the risk of subfertility following more aggressive treatment
could not be stratified and remains unclear. Furthermore, we were
not able to assess whether the interval from treatment to pregnancy
or first attempt to conceive affects the outcomes. These were not
found to be important determinants of the obstetric outcomes in
a previously published population-based study (Heinonen 2013).
Womenwith subfertility and a history of cervical treatment should
be informed that this is unlikely to be related to their treatment.
Women enquiring about the impact that cervical treatment may
have on their fertility should be advised that fertility is not com-
promised. Women in the early weeks of pregnancy or pre-concep-
tion should be informed that cervical treatment may be related to
an increased risk of second trimester loss (as well as preterm birth)
and that they may require more intensive surveillance antenatally.
Although we were unable to stratify the risk of second trimester
miscarriages according to the length of the cone, there is evidence
that the amount of tissue removed correlates to the risk of preterm
birth in women after excisional treatment of the cervix (Castanon
2014a; Founta 2010; Kyrgiou 2006; Kyrgiou 2015; Noehr 2009).
It would seem prudent to remove as little tissue as necessary, espe-
cially in nulliparous women with a small cervix, without compro-
mising the eradication of the disease. More sensitive tests, such as
those for human papillomavirus (HPV) DNA, should be used to
improve the detection of residual or recurrent lesions after treat-
ment and to minimise the risk of future cancer in young women
(Arbyn 2012). Every effort should be made to optimise both re-
productive and oncological outcomes for women requiring treat-
ment (Arbyn 2014; Strander 2014).
Implications for research
It may be that intrinsic deficiencies in the immune defences of
some women make them more prone to ascending infections and
persistent HPV infection. Conversely, HPV infection itself may
have an effect on antimicrobials in the cervical mucus (Kyrgiou
2015).
Future large, well designed, non-randomised studies are required
to carefully explore possible associations between treatment for
CIN and subsequent fertility and early and late pregnancy out-
comes, stratifying by cone length, proportion of cervix excised
or ablated, interval from treatment to conception and treatment
technique. Research activities should include prospective collec-
tion of cohorts with careful documentation of confounders and
should include only women with an intention to conceive for the
reporting of the fertility outcomes. As the impact of ablative tech-
niques on the risk of second trimester miscarriage has never been
explored, this should be further evaluated or explored in the con-
text of a randomised head-to-head comparison of excision versus
ablation.
The exact mechanism that explains the increased risk of second
trimester loss and preterm birth associated with CIN and its treat-
ment is unclear. Althoughmost obstetricians would think that this
increase in risk is related to cervical incompetence, histological
changes in the healed cervix (Phadnis 2011) or changes in the in-
nate immune system and the vaginal microenvironment are prob-
ably important contributors. The uterus in pregnancy is protected
from ascending infection by the cervix, its mucous plug and its
synthesis of antibacterial compounds and by a ‘benign’ Lactobacil-
lus-dominated vaginal microflora (Ravel 2011). There is a clear
link between infection/inflammation and preterm birth. Remov-
ing part of the cervix, or simply its infection with HPV, may im-
pair the host’s defence mechanisms, the chemical microenviron-
ment and, as a result, the vaginal microbiome producing natural
antimicrobials (Human Microbiome Project Consortium 2012).
It may also be that intrinsic deficiencies in the immune defences of
certain individuals make themmore prone to ascending infections
when pregnant, but also HPV persistence and precancer (Kyrgiou
2015).
A better understanding of these factors may enable selection of
women at risk for CIN, and prevention with cause-directed strate-
gies (Holmes 2012a; Holmes 2012b; Jimenez 2013; Li 2011;
Nicholson 2012).
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Albrechtsen 2008
Methods Retrospective cohort study
Comparison group: external - unmatched, regression analysis for age and birth order
Information source - Cancer Registry of Norway and the National Birth Registry of
Norway
Control group identified from National Birth Registry of Norway
Participants Treated group - 15,108 women who had undergone cervical treatment between 1967-
2003 and had a subsequent pregnancy
Control group - 2,164,006 women with no history of cervical treatment who had a
pregnancy
Interventions Excision NOS (CKC, LC, LLETZ)
Outcomes Early pregnancy outcome - 2nd trimester miscarriage
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk Data obtained from national registry
Selective reporting (reporting bias) Low risk No obvious reporting bias
Other bias Unclear risk During 1980-1985 the Cancer registry in-
cluded only the grade of CIN and did
not include the treatment. The researchers
excluded those women from the treated
group and included them in the untreated
group, even though they might have had
treatment. Given the large population of
this study, it is not expected that this poten-
tial misclassification bias has affected the
results of the study to a significant extent
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All patients who gave birth between 1967-
2003 and had a previous cervical conisation
were included
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Albrechtsen 2008 (Continued)
Representative comparison group? Low risk All patients who gave birth between 1967-
2003 and did not have previous cervical
conisation were included. Patient informa-
tion was obtained from the same national
registry
Comparability of treatment groups? Low risk Regression analysis was performed for age
and birth order.
Bigrigg 1994
Methods Retrospective cohort study
Comparison group: external - matching for age, geographic location, all controls had
negative smears
Information source - questionnaires through telephone interview
Control group identified fromFamilyHealth Services Authorities cervical smear database
Participants Treated group - 76 to 229* women who had undergone cervical treatment
Control group - 66 to 229* women with no history of cervical treatment and a negative
cervical smear
*Ranges represent different number of cases and controls for every outcome in the same
study
Interventions LLETZ
Outcomes Fertility outcomes - total pregnancy rate; conception rates within given time periods
Early pregnancy complications - total miscarriages rates; ectopic pregnancy rates
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
High risk Only a proportion of the patients answered
the questionnaire (24.2%)
Selective reporting (reporting bias) Low risk No obvious reporting bias
Other bias High risk Potential recall or misclassification bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? High risk Only a proportion of the patients answered
the questionnaire so this may not be a rep-
resentative group
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Bigrigg 1994 (Continued)
Representative comparison group? Low risk Drawn from the same source as the treated
group
Comparability of treatment groups? Low risk Matching for age and geographic location
Blomfield 1993
Methods Retrospective cohort study
Comparison group: external - matching for age, parity, ethnicity
Information source - hospital records, 1989-1992
Control group identified and matched from women delivered immediately before or
after index cases
Participants Treated group - 40 women who had undergone cervical treatment and had a subsequent
pregnancy
Control group - 80 women with no history of cervical treatment who had a pregnancy
Interventions LLETZ
Outcomes Early pregnancy complications - 2nd trimester miscarriages
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk Information obtained from hospital
records
Selective reporting (reporting bias) Low risk No obvious reporting bias
Other bias Low risk No other source of bias identified
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All women who were eligible for the study
who had LLETZ at Dudley Road Hospital
between January 1982 and January 1992.
However,more than60%of thewomende-
livering at Dudley Road Hospital are non-
white
Representative comparison group? Low risk Control group matched from women de-
livered immediately before or after index
cases
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Blomfield 1993 (Continued)
Comparability of treatment groups? Low risk Matching for age, parity and ethnicity
Buller 1982
Methods Retrospective cohort study
Comparison group: internal (self-matching)
Information source - hospital records
Participants Treated group - 88 women who had undergone cervical treatment under the age of 39
years and had a subsequent pregnancy
Control group - 106 treatedwomenwhohad a pregnancy prior to their cervical treatment
Interventions CKC
Outcomes Early pregnancy complications - total, 1st and 2nd trimester miscarriage rates; ectopic
pregnancy rates; molar pregnancy rates; termination of pregnancy rates
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
High risk 227 women were eligible for the study. Of
these, 61 (26.9%) were lost to follow-up
Selective reporting (reporting bias) Low risk No obvious reporting bias
Other bias Low risk No other source of bias identified
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All women who were eligible for the study
who had CKC in two hospitals between
1968-1978
Representative comparison group? Low risk Internal matching to provide control group
Comparability of treatment groups? Low risk Internal matching
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Cruickshank 1995
Methods Retrospective cohort study
Comparison group: external - matching for maternal age, parity, height, smoking and
partner’s social class
Information source - postal questionnaires and the Aberdeen Maternity and Neonatal
Databank (1989-1991)
Participants Treated group - 149 women who had undergone previous LLETZ.
Control group - 298 women with no history of cervical treatment, identified from
Aberdeen Maternity and Neonatal Databank
Interventions LLETZ
Outcomes Early pregnancy complications - miscarriages (2nd trimester)
Notes The study included 1000 women who had undergone previous LLETZ between 1989
and 1991. 653 treated women responded to a postal questionnaire, of which 149 had
a subsequent singleton pregnancy and were included in the analysis. Two controls were
matched for each treated case
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
High risk Only a proportion of the patients whowere
contacted by post responded (34.7%)
Selective reporting (reporting bias) Low risk No obvious reporting bias
Other bias High risk Potential recall or misclassification bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? High risk Only a proportion of the patients whowere
contacted by post responded
Representative comparison group? Low risk Drawn from the same source as the treated
group
Comparability of treatment groups? Low risk Matching for maternal age, parity, height,
smoking and partner’s social class
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Frega 2013
Methods Prospective cohort study
Comparison group: external - controls had similar age, ethnicity, theywere all nulliparous
and all had spontaneous pregnancies
Information source - prospective follow-up 2003-2007
Participants Treated group - 1329 women who had undergone LLETZ
Control group - 462 pregnant women with no history of cervical treatment, identified
from general gynaecology out-patient clinics in the same hospital
Interventions LLETZ
Outcomes Early pregnancy complications - total miscarriages rates
Notes 1329 treated women agreed to participate, 493 became pregnant, 18 of whom were lost
to follow-up
462 untreated controls were enrolled, of whom 21 were lost to follow-up
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk The number of women lost to follow-up
was low (3.7%).
Selective reporting (reporting bias) Low risk No obvious reporting bias
Other bias Low risk No other source of bias identified
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All patients who had a cervical conisation
from 2003-2007 who met the inclusion
and exclusion criteria were included
Representative comparison group? Low risk Control group were non-pregnant women
referred to the general gynaecology out-pa-
tient clinics in the same hospital
Comparability of treatment groups? Low risk Each cervical treatment was performed
by the same surgeon. Controls were un-
matched
37Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Kallialla 2012
Methods Retrospective cohort study
Comparison group: external - unmatched with regression analysis for number of preg-
nancies and children, age, municipality
Information source - hospital records (1974-2001); National registers: Finnish Popula-
tion Register (to identify controls), THL, Care Registers for Social Welfare and Health
Care (pregnancy outcomes)
Participants Treated group - 6179 women who had undergone cervical treatment
Control group - 30,436 women with no history of cervical treatment
Five control women were matched to every treated woman.
Interventions Treatment NOS (CKC, LC, LLETZ, LA, CT)
Outcomes Fertility outcomes - total pregnancy rates
Notes CKC was used from 1974 to 1978, CT was used from 1978 to 1988, LC or LA was
used from 1979 to 1991, and LLETZ has been used from 1991 onwards
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk Use of a national registry
Selective reporting (reporting bias) Low risk No obvious reporting bias
Other bias Low risk No other source of bias identified
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All patients who had a cervical conisation
from 1974-2001 were included
Representative comparison group? Low risk Control group were non-pregnant women
identified from the Finnish Population
Register
Comparability of treatment groups? Low risk Regression analysis for number of pregnan-
cies and children, age, municipality
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Larsson 1982
Methods Retrospective cohort study
Comparison group: internal (self-matching), comparable for age, parity, socioeconomic
status, smoking, surgical interventions, various disease
Information source - South Swedish Regional Tumour Registry, hospital records
Participants Treated group - 294 women who had undergone cervical treatment
Control group - 341 treated women prior to their cervical treatment
Interventions CKC
Outcomes Early pregnancy outcomes - total, 1st and 2nd trimester miscarriages rates; ectopic preg-
nancy rates; termination of pregnancy rates
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Low risk Use of hospital records
Selective reporting (reporting bias) Low risk No obvious reporting bias
Other bias Low risk No other source of bias identified
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk The treated group was pooled from the
South Swedish Regional Tumour Registry
Representative comparison group? Low risk Internal matching to provide control group
Comparability of treatment groups? Low risk Internal matching for age, parity, socioeco-
nomic status, smoking, surgical interven-
tions, various diseases
Sagot 1995
Methods Retrospective cohort study
Comparison group: internal
Information source - hospital records (1982 -1992)
Participants Treated group - 71 women who had undergone cervical treatment and had a subsequent
pregnancy
Control group - 82 treated women who had a pregnancy prior to their cervical treatment
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Sagot 1995 (Continued)
Interventions LC - before 1986, hand-held laser (10/54) under GA with 2 stitches, cone-shaped 1-2
cm deep, radius 1-1.5 cm
LA for haemostasis - after 1986, micromanipulator (44/54), less radical, cylinder, 0.8-
1.8 cm deep, radius 0.6-0.8 cm
Outcomes Early pregnancy complications - total, 1st and 2nd trimester miscarriage rates; ectopic
pregnancy rates; molar pregnancy rates; termination of pregnancy rates
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
High risk Of the 222 women who underwent LC be-
tween 1 July 1982 and 30 June 1992, 48
(21.6%) could not be contacted
Selective reporting (reporting bias) Low risk No obvious reporting bias
Other bias Low risk No other source of bias identified
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All patients who had a cervical conisation
from 1983-1992, were considered fertile
(under 39 years, no history of hysterectomy
or female sterilization) and had one ormore
pregnancies since treatmentwere contacted
to participate
Representative comparison group? Low risk Internal matching to provide control group
Comparability of treatment groups? Low risk Internal matching
Sjoborg 2007
Methods Retrospective cohort study
Comparison group: external - matching for age, parity, plurality and regression analysis
for smoking, marital status and education
Information source - national registry with written patient consent (1990-1999)
Control group identified from National Birth Registry of Norway
Participants Treated group - 742 women who had undergone cervical treatment and had a subsequent
pregnancy
Control group - 742 women with no previous history of cervical treatment who had a
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Sjoborg 2007 (Continued)
pregnancy
Interventions LC, LLETZ
Outcomes Early pregnancy complications - 2nd trimester miscarriage rates
Notes 2393 treated women contacted via post, of which 742 responded to provide written
consent to participate and were included
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
High risk Only a proportion of the patients whowere
contacted by post responded (69%)
Selective reporting (reporting bias) Low risk No obvious reporting bias
Other bias Low risk No other source of bias identified
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Unclear risk Because it is a multi-centre study, the
treated group is probably representative.
However, only a proportion of the patients
that were contacted by post responded
Representative comparison group? Low risk Drawn from the same source
Comparability of treatment groups? Low risk Matching for age, parity, plurality and re-
gression analysis for smoking, marital sta-
tus and education
Spitzer 1995
Methods Retrospective cohort study
Comparison group: internal (self-matching) matched for age and parity
Information source - hospital records andquestionnaires (bymail, telephone or in person)
Participants Treated group - 433 women who had undergone cervical treatment
Control group - 433 treated women prior to their cervical treatment
Interventions LC, LA
Outcomes Fertility outcomes - total pregnancy rates
Early pregnancy complications - total miscarriage rates; ectopic pregnancy rates; termi-
nation of pregnancy rates
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Spitzer 1995 (Continued)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
High risk Only 47.9% responded to the question-
naires
Selective reporting (reporting bias) Low risk No obvious reporting bias
Other bias High risk Potential recall or misclassification bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? High risk Only a proportion of the patients re-
sponded to the questionnaires
Representative comparison group? Low risk Internal matching to provide control group
Comparability of treatment groups? Low risk Internal matching
Spracklen 2013
Methods Retrospective cohort study
Comparison group:
A) External - unmatched but includes regression analysis for age, education, household
income, race, parity, pre-pregnancy BMI, smoking, cervical surgery, case status
B) Women attending colposcopy but not treated
Information source - birth register, telephone interview
All potential case and control subjects were identified and selected from the Iowa elec-
tronic birth certificate file
Participants Treated group - 152 women who had undergone cervical treatment and had a subsequent
pregnancy
Control groups - 1021 women with no history of cervical treatment or colposcopy
who had a pregnancy; 152 women who underwent colposcopy and had a subsequent
pregnancy
Interventions Treatment NOS (CKC, LLETZ, CT, LA)
Outcomes Fertility outcomes - conception within a given period
Notes
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Spracklen 2013 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
High risk Only a proportion of the women were
reached by phone and then gave their con-
sent (52.6%)
Selective reporting (reporting bias) Low risk No obvious reporting bias
Other bias High risk Potential recall or misclassification bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Unclear risk Because this is a population-based study,
the treated group is probably representa-
tive. However, only a proportion of the
women were reached by phone and then
gave their consent
Representative comparison group? Low risk Drawn from the same source
Comparability of treatment groups? Low risk Regression analysis for age, education,
household income, race, parity, pre-preg-
nancy BMI, smoking, cervical surgery, case
status
Tan 2004
Methods Retrospective cohort study
Comparison group: external - matching for age, parity
Information source - hospital records for women under 35 years of age from 1995-1998
Participants Treated group - 119 women under 35 years of age who had undergone cervical treatment
Control group - 119 women with no previous history of cervical treatment
Interventions LLETZ
Outcomes Early pregnancy complications - total miscarriage rates
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
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Tan 2004 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
High risk 168 women were eligible for the study. Of
these, 49 (29.2%) were excluded because
their notes could not be retrieved, with no
further details given by the authors
Selective reporting (reporting bias) Low risk No obvious reporting bias
Other bias Low risk No other source of bias identified
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk All patients who had a cervical conisation
from 1995-1998, were under 35 years of
age and had hospital records available for
review were included
Representative comparison group? Low risk Drawn from the same source
Comparability of treatment groups? Low risk Matching for age and parity
Turlington 1996
Methods Retrospective cohort study
Comparison group: women attending colposcopy with biopsy but no treatment
Information source - telephone interview, mail questionnaire
Control group identified in colposcopy clinics; all had colposcopy +/- punch biopsy
Participants Treated group - 54 women who had undergone cervical treatment
Control groups - 57 women seen in colposcopy clinic with no previous history of cervical
treatment
Interventions LLETZ
Outcomes Fertility outcomes - total pregnancy rates; pregnancy rates in women wishing to conceive
Early pregnancy outcomes - total miscarriages rates; termination of pregnancy rates
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
High risk Only a proportion of the patients re-
sponded to the postal questionnaire or tele-
phone interview (29.7%)
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Turlington 1996 (Continued)
Selective reporting (reporting bias) Low risk No obvious reporting bias
Other bias High risk Potential recall or misclassification bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? High risk Only a proportion of the patients re-
sponded to the postal questionnaire or tele-
phone interview
Representative comparison group? Low risk Control population also recruited fromcol-
poscopy clinic
Comparability of treatment groups? Unclear risk No description of matching, although the
comparison group was taken from women
who were seen in colposcopy and had
biospy but no treatment
Weber 1979
Methods Retrospective cohort study
Comparison group: partly external - matching for age, parity; partly internal (self-match-
ing)
Information source - interview, postal questionnaire
Participants Treated group - 21 women who had undergone cervical treatment
Control groups - 20 women with no history of cervical treatment
Interventions CKC
Outcomes Fertility outcomes - pregnancy rates in women wishing to conceive; conception rates
within given time
Early pregnancy outcomes - total, 1st and2ndmiscarriage rates; terminationof pregnancy
rates
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Data acquired from hospital records and
interviews; at risk of incomplete outcomes
data
Selective reporting (reporting bias) Unclear risk No obvious reporting bias
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Weber 1979 (Continued)
Other bias High risk Potential recall or misclassification bias
Relevant assignment described? Low risk Yes, treatment performed on clinical
grounds
Representative intervention group? Low risk The treated group was pooled from the
records of two hospitals
Representative comparison group? Low risk Same source as treated group
Comparability of treatment groups? Low risk Matching for age, parity and partly self-
matching
CKC: cold knife conisation
BMI: body mass index
CT: computerized tomography
GA: general anaesthetic
LA: laser ablation
LC: laser conisation
LLETZ: large loop excision of the transformation zone
NOS: not otherwise specified
THL: National Institute for Health and Welfare
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Acharya 2004 No untreated control group
Anderson 1984 No untreated control group
Armarnik 2011 No untreated control group
Berretta 2013 No untreated control group
Braet 1994 No untreated control group
Conner 2013 No untreated control group
Ferenczy 1995 No untreated control group
Forsmo 1996 No untreated control group
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(Continued)
Gordon 1991 No untreated control group
Haffenden 1993 No untreated control group
Hagen 1993 No untreated control group
Jones 1979 No untreated control group
Keijser 1992 No untreated control group
Khalid 2012 No untreated control group
Kuoppala 1986 No untreated control group
Luesley 1985 No untreated control group
Macvicar 1968 No untreated control group
Mathevet 2003 No untreated control group
Mazouni 2005 No untreated control group
Michelin 2009 No untreated control group
Paraskevaidis 2002 No untreated control group
Raio 1997 No untreated control group
Shanbhag 2009 Does not include early pregnancy complications
van de Vijver 2010 No untreated control group
Characteristics of studies awaiting assessment [ordered by study ID]
Castanon 2013
Methods Cohort study with a nested case-control study
Participants Women with a histological sample taken at colposcopy between 1989 and 2011
Interventions Unclear
Outcomes Early pregnancy outcomes - 2nd trimester miscarriage
Notes Conference abstract
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Castanon 2014a
Methods Nested case-control study
Participants Women with a histological sample taken at colposcopy between 1989 and 2011
Interventions Unclear
Outcomes Early pregnancy outcomes - 2nd trimester miscarriage
Notes Conference abstract
Chatterjee 2014
Methods Retrospective cohort study
Participants Women age < 49 who underwent an excisional procedure for cervical dysplasia between 2000 and 2010
Interventions Excisional treatment
Outcomes Early pregnancy outcomes - 2nd trimester miscarriage
Notes Conference abstract
Gay 2009
Methods Unclear
Participants Unclear
Interventions Unclear
Outcomes Unclear
Notes Conference abstract
Hong 2014
Methods Retrospective cohort
Participants Women undergoing treatment for high grade CIN
Interventions Bovie electroknife conization and cold knife conization
Outcomes Early pregnancy outcomes - unclear
Notes Conference abstract
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Hongo 2012
Methods Retrospective cohort
Participants Women with history of laser conisation prior to pregnancy
Interventions Laser conisation
Outcomes Early pregnancy outcomes - miscarriage
Notes Conference abstract
Jolley 2010
Methods Retrospective cohort study
Participants Women with history of previous cervical surgery
Interventions Cervical surgery NOS
Outcomes Early pregnancy outcomes - unclear
Notes Conference abstract
Khan 2014
Methods Prospective cohort study
Participants Women undergoing cone biopsy from January 2008 to December 2010
Interventions Conisation NOS
Outcomes Fertility outcomes - pregnancy rates
Early pregnancy outcomes - miscarriage, 2nd trimester miscarriage
Notes Conference abstract
Kundu 2014
Methods Retrospective cohort study
Participants 252 patients, who had undergone LLETZ previously and delivered in Galway University Hospital between January
2010 and December 2012
Interventions LLETZ
Outcomes Early pregnancy outcomes - miscarriage, 2nd trimester miscarriage
Notes Conference abstract
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Kyrgiou 2013
Methods Prospective observational study
Participants Women planned to undergo excisional treatment for CIN who wish to have future pregnancies
Interventions Excisional treatment NOS
Outcomes Fertility outcomes - pregnancy rates
Early pregnancy outcomes - miscarriage, 1st trimester miscarriage, 2nd trimester miscarriage
Notes Conference abstract
Kyrgiou 2013b
Methods Retrospective cohort
Participants Pregnant women who had excisional treatment prior to their first pregnancy
Interventions Excisional treatment NOS
Outcomes Early pregnancy outcomes - miscarriage, 1st trimester miscarriage, 2nd trimester miscarriage
Notes Conference abstract
Kyrgiou 2014
Methods Prospective observational feasibility study
Participants Women (21-45 years old) planned for excisional CIN treatment
Interventions Excisional treatment NOS
Outcomes Fertility outcomes - pregnancy rates
Early pregnancy outcomes - miscarriage, 1st trimester miscarriage, 2nd trimester miscarriage
Notes Conference abstract
Liu 2009
Methods Prospective cohort study
Participants 269 patients with CIN grade II-III who wanted to conceive
Interventions LEEP or CKC
Outcomes Fertility outcomes - pregnancy rates
Early pregnancy outcomes - miscarriage, 1st trimester miscarriage, 2nd trimester miscarriage
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Liu 2009 (Continued)
Notes Conference abstract
McGee 2012
Methods Retrospective cohort study
Participants Women with one or more deliveries following exposure to CEP was compared to women referred to colposcopy with
a cytologic abnormality not exposed to a CEP
Interventions Cervical excisional procedures - CKC, LEEP, CT, LC, LA
Outcomes Unclear - ’adverse obstetric outcomes’
Notes Conference abstract
Mozo De Rosales 2009
Methods Retrospective cohort study
Participants Women with a history of conisation
Interventions Conisation NOS
Outcomes Early pregnancy outcomes - unclear
Notes Conference abstract
Nehls 2010
Methods Retrospective cohort study
Participants Women with a history of conisation
Interventions Conisation NOS
Outcomes Early pregnancy outcomes - unclear
Notes Conference abstract
Papoutsis 2013
Methods Retrospective cohort
Participants Women having had single and repeat LLETZ conisation for CIN pathology were identified from the colposcopy
database during a 14 year period (1998-2012)
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Papoutsis 2013 (Continued)
Interventions LLETZ
Outcomes Early pregnancy outcomes - unclear
Notes Conference abstract
Peebles 2013
Methods Record linkage study
Participants Women with cervical histology between 1987 and 2009
Interventions Unclear
Outcomes Early pregnancy outcomes - miscarriages
Notes Conference abstract
Pinborg 2014
Methods National controlled cohort study
Participants Women with history of conisation
Interventions Conisation NOS
Outcomes Early pregnancy outcomes - miscarriage, 2nd trimester miscarriage
Notes Conference abstract
Ruengkhachorn 2013
Methods Retrospective cohort study
Participants Women who underwent LEEP during 6-year period in Siriraj Hospital, Mahidol University, Thailand
Interventions LEEP
Outcomes Ferility outcomes - unclear
Early pregnancy outcomes - unclear
Notes Conference abstract
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Smrkolj 2009
Methods Retrospective cohort study
Participants Women with a history of conisation
Interventions Conisation NOS
Outcomes Early pregnancy outcomes - unclear
Notes Conference abstract
Song 2009
Methods Prospective cohort study
Participants Women with CIN
Interventions Unclear
Outcomes Ferility outcomes - unclear
Early pregnancy outcomes - unclear
Notes Conference abstract
Underwood 2013
Methods Retrospective cohort study
Participants All patients (n = 614) undergoing cold coagulation at the Shrewsbury and Telford National Health Services Trust
during the period of 2000-2012
Interventions Cold coagulation
Outcomes Early pregnancy outcomes - unclear
Notes Conference abstract
Vasiliu 2010
Methods Retrospective cohort study
Participants Women undergoing LEEP
Interventions LEEP
Outcomes Early pregnancy outcomes - unclear
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Vasiliu 2010 (Continued)
Notes Conference abstract
CEP: cervical excision procedure
CIN: cervical intraepithelial neoplasia
CKC: cold knife conisation
LEEP: loop electrosurgical excisional procedure
LLETZ: large loop excision of the transformation zone
NOS: not otherwise specified
Unclear: authors were unable to ascertain whether relevant outcomes were presented from conference abstract
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D A T A A N D A N A L Y S E S
Comparison 1. Fertility outcomes
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Total pregnancy rates 4 38050 Risk Ratio (IV, Random, 95% CI) 1.29 [1.02, 1.64]
1.1 LEEP/LLETZ versus no
treatment
2 569 Risk Ratio (IV, Random, 95% CI) 1.00 [0.67, 1.48]
1.2 Laser conisation versus no
treatment
1 200 Risk Ratio (IV, Random, 95% CI) 2.39 [1.70, 3.37]
1.3 Laser ablation versus no
treatment
1 666 Risk Ratio (IV, Random, 95% CI) 1.41 [1.22, 1.63]
1.4 Treatment not specified
versus no treatment
1 36615 Risk Ratio (IV, Random, 95% CI) 1.09 [1.06, 1.13]
2 Pregnancy rate in women with
intention to conceive
2 70 Risk Ratio (IV, Random, 95% CI) 0.93 [0.80, 1.08]
3 Conception within 0-3 months
(excisional treatment versus no
treatment)
2 175 Risk Ratio (IV, Random, 95% CI) 0.89 [0.67, 1.19]
4 Conception within 0-6 months
(excisional treatment versus no
treatment)
2 175 Risk Ratio (IV, Random, 95% CI) 1.03 [0.89, 1.19]
5 Conception within 0-9 months
(excisional treatment versus no
treatment)
1 41 Risk Ratio (IV, Random, 95% CI) 1.03 [0.66, 1.59]
6 Conception within 0-12 months
(excisional treatment versus no
treatment)
2 175 Risk Ratio (IV, Random, 95% CI) 1.04 [0.94, 1.16]
7 Conception within 0-24 months
(excisional treatment versus no
treatment)
1 41 Risk Ratio (IV, Random, 95% CI) 0.95 [0.76, 1.20]
8 Conception >12 months
(treatment versus no treatment)
3 1348 Risk Ratio (IV, Random, 95% CI) 1.27 [0.67, 2.39]
8.1 Excisional treatment
versus no treatment
3 877 Risk Ratio (IV, Random, 95% CI) 1.04 [0.41, 2.63]
8.2 Ablative treatment versus
no treatment
1 471 Risk Ratio (IV, Random, 95% CI) 1.92 [1.00, 3.68]
9 Conception >12 months
(treatment versus no treatment)
3 1348 Risk Ratio (IV, Random, 95% CI) 1.45 [0.89, 2.36]
9.1 CKC versus no treatment 2 396 Risk Ratio (IV, Random, 95% CI) 1.51 [0.78, 2.92]
9.2 LEEP/LLETZ versus no
treatment
2 481 Risk Ratio (IV, Random, 95% CI) 1.06 [0.26, 4.40]
9.3 Laser ablation versus no
treatment
1 132 Risk Ratio (IV, Random, 95% CI) 2.71 [0.95, 7.67]
9.4 Cryotherapy versus no
treatment
1 339 Risk Ratio (IV, Random, 95% CI) 1.61 [0.70, 3.70]
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10 Conception >12 months
(colposcopy only versus no
treatment)
1 1172 Risk Ratio (IV, Random, 95% CI) 1.02 [0.59, 1.79]
11 Conception >12 months
(treatment versus colposcopy
only)
1 303 Risk Ratio (IV, Random, 95% CI) 1.91 [1.02, 3.59]
11.1 Excisional treatment
versus colposcopy only
1 181 Risk Ratio (IV, Random, 95% CI) 1.85 [0.83, 4.16]
11.2 Ablative treatment versus
colposcopy only
1 122 Risk Ratio (IV, Random, 95% CI) 2.0 [0.73, 5.51]
12 Conception >12 months
(treatment versus colposcopy
only)
1 303 Risk Ratio (IV, Random, 95% CI) 1.88 [0.99, 3.55]
12.1 CKC versus colposcopy
only
1 91 Risk Ratio (IV, Random, 95% CI) 1.71 [0.54, 5.45]
12.2 LEEP/LLETZ versus
colposcopy only
1 90 Risk Ratio (IV, Random, 95% CI) 2.0 [0.65, 6.17]
12.3 Laser ablation versus
colposcopy only
1 34 Risk Ratio (IV, Random, 95% CI) 4.0 [0.50, 32.20]
12.4 Cryotherapy versus
colposcopy only
1 88 Risk Ratio (IV, Random, 95% CI) 1.5 [0.45, 4.95]
13 Conception >36 months
(treatment versus no treatment)
1 134 Risk Ratio (IV, Random, 95% CI) 0.69 [0.19, 2.45]
Comparison 2. Early pregnancy outcomes
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Miscarriage rates (treatment
versus no treatment)
10 39504 Risk Ratio (IV, Random, 95% CI) 1.04 [0.90, 1.21]
1.1 Excisional treatment
versus no treatment
9 2530 Risk Ratio (IV, Random, 95% CI) 1.07 [0.87, 1.31]
1.2 Ablative treatment versus
no treatment
1 359 Risk Ratio (IV, Random, 95% CI) 0.65 [0.39, 1.09]
1.3 Treatment not specified
versus no treatment
1 36615 Risk Ratio (IV, Random, 95% CI) 1.11 [0.93, 1.31]
2 Miscarriage rates (treatment
versus no treatment)
10 39504 Risk Ratio (IV, Random, 95% CI) 1.04 [0.90, 1.21]
2.1 CKC versus no treatment 3 950 Risk Ratio (IV, Random, 95% CI) 1.30 [0.92, 1.83]
2.2 LLETZ/LEEP versus no
treatment
4 1332 Risk Ratio (IV, Random, 95% CI) 1.03 [0.77, 1.36]
2.3 Laser conisation versus no
treatment
2 248 Risk Ratio (IV, Random, 95% CI) 0.69 [0.28, 1.69]
2.4 Laser ablation versus no
treatment
1 359 Risk Ratio (IV, Random, 95% CI) 0.65 [0.39, 1.09]
2.5 Treatment not specified
versus no treatment
1 36615 Risk Ratio (IV, Random, 95% CI) 1.11 [0.93, 1.31]
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3 1st trimester Miscarriage rates
(treatment versus no treatment)
4 1103 Risk Ratio (IV, Random, 95% CI) 1.16 [0.80, 1.69]
3.1 CKC versus no treatment 3 950 Risk Ratio (IV, Random, 95% CI) 1.20 [0.78, 1.83]
3.2 Laser Conisation versus
no treatment
1 153 Risk Ratio (IV, Random, 95% CI) 1.05 [0.47, 2.33]
4 2nd trimester miscarriage rates
(treatment versus no treatment)
8 2.182268E6 Risk Ratio (IV, Random, 95% CI) 2.61 [1.46, 4.65]
4.1 CKC versus no treatment 3 950 Risk Ratio (IV, Random, 95% CI) 1.55 [0.79, 3.01]
4.2 LLETZ/LEEP versus no
treatment
2 567 Risk Ratio (IV, Random, 95% CI) 1.98 [0.48, 8.21]
4.3 Laser conisation versus no
treatment
1 153 Risk Ratio (IV, Random, 95% CI) 0.0 [0.0, 0.0]
4.4 Excisional treatment not
specified versus no treatment
2 2.180598E6 Risk Ratio (IV, Random, 95% CI) 3.82 [3.35, 4.35]
5 Ectopic pregnancy (treatment
versus no treatment)
6 38193 Risk Ratio (IV, Random, 95% CI) 1.89 [1.50, 2.39]
5.1 Excisional treatment
versus no treatment
5 1219 Risk Ratio (IV, Random, 95% CI) 1.76 [0.62, 5.02]
5.2 Ablative treatment versus
no treatment
1 359 Risk Ratio (IV, Random, 95% CI) 1.77 [0.35, 9.02]
5.3 Treatment not specified
versusno treatment
1 36615 Risk Ratio (IV, Random, 95% CI) 1.91 [1.50, 2.44]
6 Ectopic pregnancy (treatment
versus no treatment)
6 38193 Risk Ratio (IV, Random, 95% CI) 1.89 [1.50, 2.39]
6.1 CKC versus no treatment 2 829 Risk Ratio (IV, Random, 95% CI) 6.83 [1.50, 31.02]
6.2 LLETZ/LEEP versus no
treatment
1 142 Risk Ratio (IV, Random, 95% CI) 0.87 [0.13, 6.00]
6.3 Laser conisation versus no
treatment
2 248 Risk Ratio (IV, Random, 95% CI) 0.82 [0.23, 2.99]
6.4 Laser ablation versus no
treatment
1 359 Risk Ratio (IV, Random, 95% CI) 1.77 [0.35, 9.02]
6.5 Treatment not specified
versus no treatment
1 36615 Risk Ratio (IV, Random, 95% CI) 1.91 [1.50, 2.44]
7Molar pregnancy rates (treatment
versus no treatment)
2 36809 Risk Ratio (IV, Fixed, 95% CI) 1.08 [0.80, 1.47]
7.1 CKC versus no treatment 1 194 Risk Ratio (IV, Fixed, 95% CI) 0.40 [0.02, 9.72]
7.2 Treatment not specified
versus no treatment
1 36615 Risk Ratio (IV, Fixed, 95% CI) 1.09 [0.81, 1.49]
8 Termination of pregnancy
rates (Treatment versus no
treatment)
7 38208 Risk Ratio (IV, Random, 95% CI) 1.71 [1.31, 2.22]
8.1 Excisional treatment
versus no treatment
6 1234 Risk Ratio (IV, Random, 95% CI) 1.87 [1.12, 3.11]
8.2 Ablative treatment versus
no treatment
1 359 Risk Ratio (IV, Random, 95% CI) 1.54 [0.99, 2.38]
8.3 Treatment not specified
versus no treatment
1 36615 Risk Ratio (IV, Random, 95% CI) 1.52 [1.41, 1.65]
9 Termination of pregnancy rates
(treatment versus no treatment)
7 38208 Risk Ratio (IV, Random, 95% CI) 1.71 [1.31, 2.22]
9.1 CKC versus no treatment 3 950 Risk Ratio (IV, Random, 95% CI) 2.45 [1.68, 3.58]
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9.2 LLETZ/LEEP versus no
treatment
1 36 Risk Ratio (IV, Random, 95% CI) 0.28 [0.01, 5.35]
9.3 Laser conisation versus no
treatment
2 248 Risk Ratio (IV, Random, 95% CI) 1.29 [0.38, 4.36]
9.4 Laser ablation versus no
treatment
1 359 Risk Ratio (IV, Random, 95% CI) 1.54 [0.99, 2.38]
9.5 Treatment not specified
versus no treatment
1 36615 Risk Ratio (IV, Random, 95% CI) 1.52 [1.41, 1.65]
Analysis 1.1. Comparison 1 Fertility outcomes, Outcome 1 Total pregnancy rates.
Review: Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia
Comparison: 1 Fertility outcomes
Outcome: 1 Total pregnancy rates
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 LEEP/LLETZ versus no treatment
Bigrigg 1994 76/229 66/229 19.9 % 1.15 [ 0.88, 1.51 ]
Turlington 1996 15/54 21/57 11.1 % 0.75 [ 0.44, 1.30 ]
Subtotal (95% CI) 283 286 31.1 % 1.00 [ 0.67, 1.48 ]
Total events: 91 (Treated), 87 (Untreated)
Heterogeneity: Tau2 = 0.04; Chi2 = 1.83, df = 1 (P = 0.18); I2 =45%
Test for overall effect: Z = 0.01 (P = 0.99)
2 Laser conisation versus no treatment
Spitzer 1995 67/100 28/100 17.3 % 2.39 [ 1.70, 3.37 ]
Subtotal (95% CI) 100 100 17.3 % 2.39 [ 1.70, 3.37 ]
Total events: 67 (Treated), 28 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 4.98 (P < 0.00001)
3 Laser ablation versus no treatment
Spitzer 1995 210/333 149/333 24.6 % 1.41 [ 1.22, 1.63 ]
Subtotal (95% CI) 333 333 24.6 % 1.41 [ 1.22, 1.63 ]
Total events: 210 (Treated), 149 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 4.64 (P < 0.00001)
4 Treatment not specified versus no treatment
Kallialla 2012 2578/6179 11642/30436 27.0 % 1.09 [ 1.06, 1.13 ]
Subtotal (95% CI) 6179 30436 27.0 % 1.09 [ 1.06, 1.13 ]
Total events: 2578 (Treated), 11642 (Untreated)
Heterogeneity: not applicable
0.5 0.7 1 1.5 2
Favours untreated group Favours treated group
(Continued . . . )
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(. . . Continued)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Test for overall effect: Z = 5.20 (P < 0.00001)
Total (95% CI) 6895 31155 100.0 % 1.29 [ 1.02, 1.64 ]
Total events: 2946 (Treated), 11906 (Untreated)
Heterogeneity: Tau2 = 0.05; Chi2 = 32.76, df = 4 (P<0.00001); I2 =88%
Test for overall effect: Z = 2.11 (P = 0.035)
Test for subgroup differences: Chi2 = 31.06, df = 3 (P = 0.00), I2 =90%
0.5 0.7 1 1.5 2
Favours untreated group Favours treated group
Analysis 1.2. Comparison 1 Fertility outcomes, Outcome 2 Pregnancy rate in women with intention to
conceive.
Review: Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia
Comparison: 1 Fertility outcomes
Outcome: 2 Pregnancy rate in women with intention to conceive
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Turlington 1996 11/12 17/17 53.7 % 0.91 [ 0.74, 1.12 ]
Weber 1979 18/21 18/20 46.3 % 0.95 [ 0.76, 1.20 ]
Total (95% CI) 33 37 100.0 % 0.93 [ 0.80, 1.08 ]
Total events: 29 (Treated), 35 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.08, df = 1 (P = 0.77); I2 =0.0%
Test for overall effect: Z = 0.93 (P = 0.35)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
Favours untreated group Favours treated group
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Analysis 1.3. Comparison 1 Fertility outcomes, Outcome 3 Conception within 0-3 months (excisional
treatment versus no treatment).
Review: Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia
Comparison: 1 Fertility outcomes
Outcome: 3 Conception within 0-3 months (excisional treatment versus no treatment)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Bigrigg 1994 36/72 36/62 81.6 % 0.86 [ 0.63, 1.18 ]
Weber 1979 10/21 9/20 18.4 % 1.06 [ 0.55, 2.05 ]
Total (95% CI) 93 82 100.0 % 0.89 [ 0.67, 1.19 ]
Total events: 46 (Treated), 45 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.31, df = 1 (P = 0.58); I2 =0.0%
Test for overall effect: Z = 0.77 (P = 0.44)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
Favours untreated group Favours treated group
Analysis 1.4. Comparison 1 Fertility outcomes, Outcome 4 Conception within 0-6 months (excisional
treatment versus no treatment).
Review: Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia
Comparison: 1 Fertility outcomes
Outcome: 4 Conception within 0-6 months (excisional treatment versus no treatment)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Bigrigg 1994 61/72 51/62 92.8 % 1.03 [ 0.89, 1.20 ]
Weber 1979 12/21 11/20 7.2 % 1.04 [ 0.60, 1.79 ]
Total (95% CI) 93 82 100.0 % 1.03 [ 0.89, 1.19 ]
Total events: 73 (Treated), 62 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.00, df = 1 (P = 0.98); I2 =0.0%
Test for overall effect: Z = 0.40 (P = 0.69)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
Favours untreated group Favours treated group
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Analysis 1.5. Comparison 1 Fertility outcomes, Outcome 5 Conception within 0-9 months (excisional
treatment versus no treatment).
Review: Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia
Comparison: 1 Fertility outcomes
Outcome: 5 Conception within 0-9 months (excisional treatment versus no treatment)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Weber 1979 14/21 13/20 100.0 % 1.03 [ 0.66, 1.59 ]
Total (95% CI) 21 20 100.0 % 1.03 [ 0.66, 1.59 ]
Total events: 14 (Treated), 13 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.11 (P = 0.91)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
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Analysis 1.6. Comparison 1 Fertility outcomes, Outcome 6 Conception within 0-12 months (excisional
treatment versus no treatment).
Review: Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia
Comparison: 1 Fertility outcomes
Outcome: 6 Conception within 0-12 months (excisional treatment versus no treatment)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Bigrigg 1994 67/72 55/62 93.6 % 1.05 [ 0.94, 1.17 ]
Weber 1979 14/21 14/20 6.4 % 0.95 [ 0.63, 1.44 ]
Total (95% CI) 93 82 100.0 % 1.04 [ 0.94, 1.16 ]
Total events: 81 (Treated), 69 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.19, df = 1 (P = 0.66); I2 =0.0%
Test for overall effect: Z = 0.77 (P = 0.44)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
Favours untreated group Favours treated group
Analysis 1.7. Comparison 1 Fertility outcomes, Outcome 7 Conception within 0-24 months (excisional
treatment versus no treatment).
Review: Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia
Comparison: 1 Fertility outcomes
Outcome: 7 Conception within 0-24 months (excisional treatment versus no treatment)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Weber 1979 18/21 18/20 100.0 % 0.95 [ 0.76, 1.20 ]
Total (95% CI) 21 20 100.0 % 0.95 [ 0.76, 1.20 ]
Total events: 18 (Treated), 18 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.42 (P = 0.67)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
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Analysis 1.8. Comparison 1 Fertility outcomes, Outcome 8 Conception >12 months (treatment versus no
treatment).
Review: Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia
Comparison: 1 Fertility outcomes
Outcome: 8 Conception >12 months (treatment versus no treatment)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Excisional treatment versus no treatment
Bigrigg 1994 7/72 12/62 23.3 % 0.50 [ 0.21, 1.20 ]
Spracklen 2013 15/91 51/611 32.0 % 1.97 [ 1.16, 3.36 ]
Weber 1979 4/21 4/20 16.0 % 0.95 [ 0.27, 3.30 ]
Subtotal (95% CI) 184 693 71.2 % 1.04 [ 0.41, 2.63 ]
Total events: 26 (Treated), 67 (Untreated)
Heterogeneity: Tau2 = 0.48; Chi2 = 7.22, df = 2 (P = 0.03); I2 =72%
Test for overall effect: Z = 0.07 (P = 0.94)
2 Ablative treatment versus no treatment
Spracklen 2013 10/61 35/410 28.8 % 1.92 [ 1.00, 3.68 ]
Subtotal (95% CI) 61 410 28.8 % 1.92 [ 1.00, 3.68 ]
Total events: 10 (Treated), 35 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.97 (P = 0.049)
Total (95% CI) 245 1103 100.0 % 1.27 [ 0.67, 2.39 ]
Total events: 36 (Treated), 102 (Untreated)
Heterogeneity: Tau2 = 0.25; Chi2 = 8.18, df = 3 (P = 0.04); I2 =63%
Test for overall effect: Z = 0.73 (P = 0.46)
Test for subgroup differences: Chi2 = 1.14, df = 1 (P = 0.29), I2 =12%
0.2 0.5 1 2 5
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Analysis 1.9. Comparison 1 Fertility outcomes, Outcome 9 Conception >12 months (treatment versus no
treatment).
Review: Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia
Comparison: 1 Fertility outcomes
Outcome: 9 Conception >12 months (treatment versus no treatment)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC versus no treatment
Spracklen 2013 7/46 26/309 19.4 % 1.81 [ 0.83, 3.93 ]
Weber 1979 4/21 4/20 11.0 % 0.95 [ 0.27, 3.30 ]
Subtotal (95% CI) 67 329 30.3 % 1.51 [ 0.78, 2.92 ]
Total events: 11 (Treated), 30 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.74, df = 1 (P = 0.39); I2 =0.0%
Test for overall effect: Z = 1.23 (P = 0.22)
2 LEEP/LLETZ versus no treatment
Bigrigg 1994 7/72 12/62 17.2 % 0.50 [ 0.21, 1.20 ]
Spracklen 2013 8/45 25/302 20.5 % 2.15 [ 1.03, 4.47 ]
Subtotal (95% CI) 117 364 37.7 % 1.06 [ 0.26, 4.40 ]
Total events: 15 (Treated), 37 (Untreated)
Heterogeneity: Tau2 = 0.89; Chi2 = 6.29, df = 1 (P = 0.01); I2 =84%
Test for overall effect: Z = 0.08 (P = 0.94)
3 Laser ablation versus no treatment
Spracklen 2013 4/17 10/115 13.9 % 2.71 [ 0.95, 7.67 ]
Subtotal (95% CI) 17 115 13.9 % 2.71 [ 0.95, 7.67 ]
Total events: 4 (Treated), 10 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.87 (P = 0.061)
4 Cryotherapy versus no treatment
Spracklen 2013 6/44 25/295 18.0 % 1.61 [ 0.70, 3.70 ]
Subtotal (95% CI) 44 295 18.0 % 1.61 [ 0.70, 3.70 ]
Total events: 6 (Treated), 25 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.12 (P = 0.26)
Total (95% CI) 245 1103 100.0 % 1.45 [ 0.89, 2.36 ]
Total events: 36 (Treated), 102 (Untreated)
Heterogeneity: Tau2 = 0.16; Chi2 = 9.01, df = 5 (P = 0.11); I2 =45%
Test for overall effect: Z = 1.49 (P = 0.14)
Test for subgroup differences: Chi2 = 1.31, df = 3 (P = 0.73), I2 =0.0%
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Analysis 1.10. Comparison 1 Fertility outcomes, Outcome 10 Conception >12 months (colposcopy only
versus no treatment).
Review: Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia
Comparison: 1 Fertility outcomes
Outcome: 10 Conception >12 months (colposcopy only versus no treatment)
Study or subgroup
Referred to
colposcopy
Not
referred
colposcopy Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Spracklen 2013 13/151 86/1021 100.0 % 1.02 [ 0.59, 1.79 ]
Total (95% CI) 151 1021 100.0 % 1.02 [ 0.59, 1.79 ]
Total events: 13 (Referred to colposcopy), 86 (Not referred colposcopy)
Heterogeneity: not applicable
Test for overall effect: Z = 0.08 (P = 0.94)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
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Analysis 1.11. Comparison 1 Fertility outcomes, Outcome 11 Conception >12 months (treatment versus
colposcopy only).
Review: Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia
Comparison: 1 Fertility outcomes
Outcome: 11 Conception >12 months (treatment versus colposcopy only)
Study or subgroup Treated Colposcopy only Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Excisional treatment versus colposcopy only
Spracklen 2013 15/91 8/90 61.2 % 1.85 [ 0.83, 4.16 ]
Subtotal (95% CI) 91 90 61.2 % 1.85 [ 0.83, 4.16 ]
Total events: 15 (Treated), 8 (Colposcopy only)
Heterogeneity: not applicable
Test for overall effect: Z = 1.50 (P = 0.13)
2 Ablative treatment versus colposcopy only
Spracklen 2013 10/61 5/61 38.8 % 2.00 [ 0.73, 5.51 ]
Subtotal (95% CI) 61 61 38.8 % 2.00 [ 0.73, 5.51 ]
Total events: 10 (Treated), 5 (Colposcopy only)
Heterogeneity: not applicable
Test for overall effect: Z = 1.34 (P = 0.18)
Total (95% CI) 152 151 100.0 % 1.91 [ 1.02, 3.59 ]
Total events: 25 (Treated), 13 (Colposcopy only)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.01, df = 1 (P = 0.91); I2 =0.0%
Test for overall effect: Z = 2.01 (P = 0.045)
Test for subgroup differences: Chi2 = 0.01, df = 1 (P = 0.91), I2 =0.0%
0.2 0.5 1 2 5
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Analysis 1.12. Comparison 1 Fertility outcomes, Outcome 12 Conception >12 months (treatment versus
colposcopy only).
Review: Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia
Comparison: 1 Fertility outcomes
Outcome: 12 Conception >12 months (treatment versus colposcopy only)
Study or subgroup Treated Colposcopy only Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC versus colposcopy only
Spracklen 2013 7/46 4/45 30.3 % 1.71 [ 0.54, 5.45 ]
Subtotal (95% CI) 46 45 30.3 % 1.71 [ 0.54, 5.45 ]
Total events: 7 (Treated), 4 (Colposcopy only)
Heterogeneity: not applicable
Test for overall effect: Z = 0.91 (P = 0.36)
2 LEEP/LLETZ versus colposcopy only
Spracklen 2013 8/45 4/45 32.0 % 2.00 [ 0.65, 6.17 ]
Subtotal (95% CI) 45 45 32.0 % 2.00 [ 0.65, 6.17 ]
Total events: 8 (Treated), 4 (Colposcopy only)
Heterogeneity: not applicable
Test for overall effect: Z = 1.21 (P = 0.23)
3 Laser ablation versus colposcopy only
Spracklen 2013 4/17 1/17 9.3 % 4.00 [ 0.50, 32.20 ]
Subtotal (95% CI) 17 17 9.3 % 4.00 [ 0.50, 32.20 ]
Total events: 4 (Treated), 1 (Colposcopy only)
Heterogeneity: not applicable
Test for overall effect: Z = 1.30 (P = 0.19)
4 Cryotherapy versus colposcopy only
Spracklen 2013 6/44 4/44 28.5 % 1.50 [ 0.45, 4.95 ]
Subtotal (95% CI) 44 44 28.5 % 1.50 [ 0.45, 4.95 ]
Total events: 6 (Treated), 4 (Colposcopy only)
Heterogeneity: not applicable
Test for overall effect: Z = 0.67 (P = 0.51)
Total (95% CI) 152 151 100.0 % 1.88 [ 0.99, 3.55 ]
Total events: 25 (Treated), 13 (Colposcopy only)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.68, df = 3 (P = 0.88); I2 =0.0%
Test for overall effect: Z = 1.94 (P = 0.053)
Test for subgroup differences: Chi2 = 0.68, df = 3 (P = 0.88), I2 =0.0%
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Analysis 1.13. Comparison 1 Fertility outcomes, Outcome 13 Conception >36 months (treatment versus
no treatment).
Review: Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia
Comparison: 1 Fertility outcomes
Outcome: 13 Conception >36 months (treatment versus no treatment)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Bigrigg 1994 4/72 5/62 100.0 % 0.69 [ 0.19, 2.45 ]
Total (95% CI) 72 62 100.0 % 0.69 [ 0.19, 2.45 ]
Total events: 4 (Treated), 5 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.58 (P = 0.57)
Test for subgroup differences: Not applicable
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Analysis 2.1. Comparison 2 Early pregnancy outcomes, Outcome 1 Miscarriage rates (treatment versus no
treatment).
Review: Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia
Comparison: 2 Early pregnancy outcomes
Outcome: 1 Miscarriage rates (treatment versus no treatment)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Excisional treatment versus no treatment
Bigrigg 1994 5/76 6/66 1.7 % 0.72 [ 0.23, 2.26 ]
Buller 1982 10/88 10/106 3.3 % 1.20 [ 0.53, 2.76 ]
Frega 2013 69/475 62/441 18.5 % 1.03 [ 0.75, 1.42 ]
Larsson 1982 40/294 37/341 11.6 % 1.25 [ 0.82, 1.91 ]
Sagot 1995 10/71 11/82 3.5 % 1.05 [ 0.47, 2.33 ]
Spitzer 1995 7/67 7/28 2.5 % 0.42 [ 0.16, 1.08 ]
Tan 2004 14/119 11/119 4.0 % 1.27 [ 0.60, 2.69 ]
Turlington 1996 0/15 3/21 0.3 % 0.20 [ 0.01, 3.54 ]
Weber 1979 12/66 6/55 2.7 % 1.67 [ 0.67, 4.15 ]
Subtotal (95% CI) 1271 1259 48.1 % 1.07 [ 0.87, 1.31 ]
Total events: 167 (Treated), 153 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 7.32, df = 8 (P = 0.50); I2 =0.0%
Test for overall effect: Z = 0.64 (P = 0.52)
2 Ablative treatment versus no treatment
Spitzer 1995 24/210 26/149 8.0 % 0.65 [ 0.39, 1.09 ]
Subtotal (95% CI) 210 149 8.0 % 0.65 [ 0.39, 1.09 ]
Total events: 24 (Treated), 26 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.62 (P = 0.11)
3 Treatment not specified versus no treatment
Kallialla 2012 159/6179 707/30436 43.8 % 1.11 [ 0.93, 1.31 ]
Subtotal (95% CI) 6179 30436 43.8 % 1.11 [ 0.93, 1.31 ]
Total events: 159 (Treated), 707 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.18 (P = 0.24)
Total (95% CI) 7660 31844 100.0 % 1.04 [ 0.90, 1.21 ]
Total events: 350 (Treated), 886 (Untreated)
Heterogeneity: Tau2 = 0.01; Chi2 = 10.96, df = 10 (P = 0.36); I2 =9%
Test for overall effect: Z = 0.55 (P = 0.59)
Test for subgroup differences: Chi2 = 3.64, df = 2 (P = 0.16), I2 =45%
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Analysis 2.2. Comparison 2 Early pregnancy outcomes, Outcome 2 Miscarriage rates (treatment versus no
treatment).
Review: Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia
Comparison: 2 Early pregnancy outcomes
Outcome: 2 Miscarriage rates (treatment versus no treatment)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC versus no treatment
Buller 1982 10/88 10/106 3.3 % 1.20 [ 0.53, 2.76 ]
Larsson 1982 40/294 37/341 11.6 % 1.25 [ 0.82, 1.91 ]
Weber 1979 12/66 6/55 2.7 % 1.67 [ 0.67, 4.15 ]
Subtotal (95% CI) 448 502 17.6 % 1.30 [ 0.92, 1.83 ]
Total events: 62 (Treated), 53 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.35, df = 2 (P = 0.84); I2 =0.0%
Test for overall effect: Z = 1.47 (P = 0.14)
2 LLETZ/LEEP versus no treatment
Bigrigg 1994 5/76 6/66 1.7 % 0.72 [ 0.23, 2.26 ]
Frega 2013 69/475 62/441 18.5 % 1.03 [ 0.75, 1.42 ]
Tan 2004 14/119 11/119 4.0 % 1.27 [ 0.60, 2.69 ]
Turlington 1996 0/15 3/21 0.3 % 0.20 [ 0.01, 3.54 ]
Subtotal (95% CI) 685 647 24.5 % 1.03 [ 0.77, 1.36 ]
Total events: 88 (Treated), 82 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.94, df = 3 (P = 0.59); I2 =0.0%
Test for overall effect: Z = 0.17 (P = 0.86)
3 Laser conisation versus no treatment
Sagot 1995 10/71 11/82 3.5 % 1.05 [ 0.47, 2.33 ]
Spitzer 1995 7/67 7/28 2.5 % 0.42 [ 0.16, 1.08 ]
Subtotal (95% CI) 138 110 6.0 % 0.69 [ 0.28, 1.69 ]
Total events: 17 (Treated), 18 (Untreated)
Heterogeneity: Tau2 = 0.22; Chi2 = 2.12, df = 1 (P = 0.15); I2 =53%
Test for overall effect: Z = 0.81 (P = 0.42)
4 Laser ablation versus no treatment
Spitzer 1995 24/210 26/149 8.0 % 0.65 [ 0.39, 1.09 ]
Subtotal (95% CI) 210 149 8.0 % 0.65 [ 0.39, 1.09 ]
Total events: 24 (Treated), 26 (Untreated)
Heterogeneity: not applicable
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(. . . Continued)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Test for overall effect: Z = 1.62 (P = 0.11)
5 Treatment not specified versus no treatment
Kallialla 2012 159/6179 707/30436 43.8 % 1.11 [ 0.93, 1.31 ]
Subtotal (95% CI) 6179 30436 43.8 % 1.11 [ 0.93, 1.31 ]
Total events: 159 (Treated), 707 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.18 (P = 0.24)
Total (95% CI) 7660 31844 100.0 % 1.04 [ 0.90, 1.21 ]
Total events: 350 (Treated), 886 (Untreated)
Heterogeneity: Tau2 = 0.01; Chi2 = 10.96, df = 10 (P = 0.36); I2 =9%
Test for overall effect: Z = 0.55 (P = 0.59)
Test for subgroup differences: Chi2 = 5.87, df = 4 (P = 0.21), I2 =32%
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Analysis 2.3. Comparison 2 Early pregnancy outcomes, Outcome 3 1st trimester Miscarriage rates
(treatment versus no treatment).
Review: Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia
Comparison: 2 Early pregnancy outcomes
Outcome: 3 1st trimester Miscarriage rates (treatment versus no treatment)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC versus no treatment
Buller 1982 9/88 8/106 16.9 % 1.36 [ 0.55, 3.36 ]
Larsson 1982 24/294 25/341 48.4 % 1.11 [ 0.65, 1.91 ]
Weber 1979 8/66 5/55 12.5 % 1.33 [ 0.46, 3.84 ]
Subtotal (95% CI) 448 502 77.8 % 1.20 [ 0.78, 1.83 ]
Total events: 41 (Treated), 38 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.18, df = 2 (P = 0.91); I2 =0.0%
Test for overall effect: Z = 0.83 (P = 0.41)
2 Laser Conisation versus no treatment
Sagot 1995 10/71 11/82 22.2 % 1.05 [ 0.47, 2.33 ]
Subtotal (95% CI) 71 82 22.2 % 1.05 [ 0.47, 2.33 ]
Total events: 10 (Treated), 11 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.12 (P = 0.90)
Total (95% CI) 519 584 100.0 % 1.16 [ 0.80, 1.69 ]
Total events: 51 (Treated), 49 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.26, df = 3 (P = 0.97); I2 =0.0%
Test for overall effect: Z = 0.79 (P = 0.43)
Test for subgroup differences: Chi2 = 0.08, df = 1 (P = 0.78), I2 =0.0%
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Analysis 2.4. Comparison 2 Early pregnancy outcomes, Outcome 4 2nd trimester miscarriage rates
(treatment versus no treatment).
Review: Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia
Comparison: 2 Early pregnancy outcomes
Outcome: 4 2nd trimester miscarriage rates (treatment versus no treatment)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC versus no treatment
Buller 1982 1/88 2/106 5.2 % 0.60 [ 0.06, 6.53 ]
Larsson 1982 16/294 12/341 26.4 % 1.55 [ 0.74, 3.22 ]
Weber 1979 4/66 1/55 6.2 % 3.33 [ 0.38, 28.96 ]
Subtotal (95% CI) 448 502 37.8 % 1.55 [ 0.79, 3.01 ]
Total events: 21 (Treated), 15 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.09, df = 2 (P = 0.58); I2 =0.0%
Test for overall effect: Z = 1.28 (P = 0.20)
2 LLETZ/LEEP versus no treatment
Blomfield 1993 2/40 1/80 5.3 % 4.00 [ 0.37, 42.80 ]
Cruickshank 1995 2/149 3/298 8.6 % 1.33 [ 0.23, 7.89 ]
Subtotal (95% CI) 189 378 13.8 % 1.98 [ 0.48, 8.21 ]
Total events: 4 (Treated), 4 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.53, df = 1 (P = 0.47); I2 =0.0%
Test for overall effect: Z = 0.94 (P = 0.35)
3 Laser conisation versus no treatment
Sagot 1995 0/71 0/82 Not estimable
Subtotal (95% CI) 71 82 Not estimable
Total events: 0 (Treated), 0 (Untreated)
Heterogeneity: not applicable
Test for overall effect: not applicable
4 Excisional treatment not specified versus no treatment
Albrechtsen 2008 226/15108 8501/2164006 44.7 % 3.81 [ 3.34, 4.34 ]
Sjoborg 2007 7/742 0/742 3.7 % 15.00 [ 0.86, 262.16 ]
Subtotal (95% CI) 15850 2164748 48.4 % 3.82 [ 3.35, 4.35 ]
Total events: 233 (Treated), 8501 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.88, df = 1 (P = 0.35); I2 =0.0%
Test for overall effect: Z = 20.05 (P < 0.00001)
Total (95% CI) 16558 2165710 100.0 % 2.61 [ 1.46, 4.65 ]
Total events: 258 (Treated), 8520 (Untreated)
Heterogeneity: Tau2 = 0.19; Chi2 = 10.05, df = 6 (P = 0.12); I2 =40%
Test for overall effect: Z = 3.25 (P = 0.0011)
Test for subgroup differences: Chi2 = 7.56, df = 2 (P = 0.02), I2 =74%
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Analysis 2.5. Comparison 2 Early pregnancy outcomes, Outcome 5 Ectopic pregnancy (treatment versus
no treatment).
Review: Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia
Comparison: 2 Early pregnancy outcomes
Outcome: 5 Ectopic pregnancy (treatment versus no treatment)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Excisional treatment versus no treatment
Bigrigg 1994 2/76 2/66 1.4 % 0.87 [ 0.13, 6.00 ]
Buller 1982 3/88 1/106 1.1 % 3.61 [ 0.38, 34.13 ]
Larsson 1982 10/294 1/341 1.3 % 11.60 [ 1.49, 90.07 ]
Sagot 1995 2/71 2/82 1.4 % 1.15 [ 0.17, 7.99 ]
Spitzer 1995 3/67 2/28 1.8 % 0.63 [ 0.11, 3.55 ]
Subtotal (95% CI) 596 623 7.0 % 1.76 [ 0.62, 5.02 ]
Total events: 20 (Treated), 8 (Untreated)
Heterogeneity: Tau2 = 0.43; Chi2 = 5.69, df = 4 (P = 0.22); I2 =30%
Test for overall effect: Z = 1.05 (P = 0.29)
2 Ablative treatment versus no treatment
Spitzer 1995 5/210 2/149 2.0 % 1.77 [ 0.35, 9.02 ]
Subtotal (95% CI) 210 149 2.0 % 1.77 [ 0.35, 9.02 ]
Total events: 5 (Treated), 2 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.69 (P = 0.49)
3 Treatment not specified versusno treatment
Kallialla 2012 89/6179 229/30436 90.9 % 1.91 [ 1.50, 2.44 ]
Subtotal (95% CI) 6179 30436 90.9 % 1.91 [ 1.50, 2.44 ]
Total events: 89 (Treated), 229 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 5.23 (P < 0.00001)
Total (95% CI) 6985 31208 100.0 % 1.89 [ 1.50, 2.39 ]
Total events: 114 (Treated), 239 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 5.77, df = 6 (P = 0.45); I2 =0.0%
Test for overall effect: Z = 5.40 (P < 0.00001)
Test for subgroup differences: Chi2 = 0.03, df = 2 (P = 0.98), I2 =0.0%
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Analysis 2.6. Comparison 2 Early pregnancy outcomes, Outcome 6 Ectopic pregnancy (treatment versus
no treatment).
Review: Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia
Comparison: 2 Early pregnancy outcomes
Outcome: 6 Ectopic pregnancy (treatment versus no treatment)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC versus no treatment
Buller 1982 3/88 1/106 1.1 % 3.61 [ 0.38, 34.13 ]
Larsson 1982 10/294 1/341 1.3 % 11.60 [ 1.49, 90.07 ]
Subtotal (95% CI) 382 447 2.3 % 6.83 [ 1.50, 31.02 ]
Total events: 13 (Treated), 2 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.57, df = 1 (P = 0.45); I2 =0.0%
Test for overall effect: Z = 2.49 (P = 0.013)
2 LLETZ/LEEP versus no treatment
Bigrigg 1994 2/76 2/66 1.4 % 0.87 [ 0.13, 6.00 ]
Subtotal (95% CI) 76 66 1.4 % 0.87 [ 0.13, 6.00 ]
Total events: 2 (Treated), 2 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.14 (P = 0.89)
3 Laser conisation versus no treatment
Sagot 1995 2/71 2/82 1.4 % 1.15 [ 0.17, 7.99 ]
Spitzer 1995 3/67 2/28 1.8 % 0.63 [ 0.11, 3.55 ]
Subtotal (95% CI) 138 110 3.2 % 0.82 [ 0.23, 2.99 ]
Total events: 5 (Treated), 4 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.21, df = 1 (P = 0.64); I2 =0.0%
Test for overall effect: Z = 0.30 (P = 0.77)
4 Laser ablation versus no treatment
Spitzer 1995 5/210 2/149 2.0 % 1.77 [ 0.35, 9.02 ]
Subtotal (95% CI) 210 149 2.0 % 1.77 [ 0.35, 9.02 ]
Total events: 5 (Treated), 2 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.69 (P = 0.49)
5 Treatment not specified versus no treatment
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(. . . Continued)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Kallialla 2012 89/6179 229/30436 90.9 % 1.91 [ 1.50, 2.44 ]
Subtotal (95% CI) 6179 30436 90.9 % 1.91 [ 1.50, 2.44 ]
Total events: 89 (Treated), 229 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 5.23 (P < 0.00001)
Total (95% CI) 6985 31208 100.0 % 1.89 [ 1.50, 2.39 ]
Total events: 114 (Treated), 239 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 5.77, df = 6 (P = 0.45); I2 =0.0%
Test for overall effect: Z = 5.40 (P < 0.00001)
Test for subgroup differences: Chi2 = 5.00, df = 4 (P = 0.29), I2 =20%
0.05 0.2 1 5 20
Favours untreated group Favours treated group
Analysis 2.7. Comparison 2 Early pregnancy outcomes, Outcome 7 Molar pregnancy rates (treatment
versus no treatment).
Review: Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia
Comparison: 2 Early pregnancy outcomes
Outcome: 7 Molar pregnancy rates (treatment versus no treatment)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Fixed,95% CI IV,Fixed,95% CI
1 CKC versus no treatment
Buller 1982 0/88 1/106 0.9 % 0.40 [ 0.02, 9.72 ]
Subtotal (95% CI) 88 106 0.9 % 0.40 [ 0.02, 9.72 ]
Total events: 0 (Treated), 1 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.56 (P = 0.57)
2 Treatment not specified versus no treatment
Kallialla 2012 50/6179 225/30436 99.1 % 1.09 [ 0.81, 1.49 ]
Subtotal (95% CI) 6179 30436 99.1 % 1.09 [ 0.81, 1.49 ]
Total events: 50 (Treated), 225 (Untreated)
Heterogeneity: not applicable
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(. . . Continued)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Fixed,95% CI IV,Fixed,95% CI
Test for overall effect: Z = 0.58 (P = 0.56)
Total (95% CI) 6267 30542 100.0 % 1.08 [ 0.80, 1.47 ]
Total events: 50 (Treated), 226 (Untreated)
Heterogeneity: Chi2 = 0.38, df = 1 (P = 0.54); I2 =0.0%
Test for overall effect: Z = 0.52 (P = 0.60)
Test for subgroup differences: Chi2 = 0.38, df = 1 (P = 0.54), I2 =0.0%
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Analysis 2.8. Comparison 2 Early pregnancy outcomes, Outcome 8 Termination of pregnancy rates
(Treatment versus no treatment).
Review: Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia
Comparison: 2 Early pregnancy outcomes
Outcome: 8 Termination of pregnancy rates (Treatment versus no treatment)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 Excisional treatment versus no treatment
Buller 1982 24/88 15/106 13.4 % 1.93 [ 1.08, 3.44 ]
Larsson 1982 47/294 19/341 15.8 % 2.87 [ 1.72, 4.78 ]
Sagot 1995 6/71 10/82 6.3 % 0.69 [ 0.27, 1.81 ]
Spitzer 1995 23/67 4/28 6.2 % 2.40 [ 0.91, 6.31 ]
Turlington 1996 0/15 2/21 0.8 % 0.28 [ 0.01, 5.35 ]
Weber 1979 5/66 1/55 1.5 % 4.17 [ 0.50, 34.61 ]
Subtotal (95% CI) 601 633 44.0 % 1.87 [ 1.12, 3.11 ]
Total events: 105 (Treated), 51 (Untreated)
Heterogeneity: Tau2 = 0.16; Chi2 = 8.90, df = 5 (P = 0.11); I2 =44%
Test for overall effect: Z = 2.40 (P = 0.016)
2 Ablative treatment versus no treatment
Spitzer 1995 52/210 24/149 18.8 % 1.54 [ 0.99, 2.38 ]
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Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Subtotal (95% CI) 210 149 18.8 % 1.54 [ 0.99, 2.38 ]
Total events: 52 (Treated), 24 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.93 (P = 0.053)
3 Treatment not specified versus no treatment
Kallialla 2012 695/6179 2245/30436 37.3 % 1.52 [ 1.41, 1.65 ]
Subtotal (95% CI) 6179 30436 37.3 % 1.52 [ 1.41, 1.65 ]
Total events: 695 (Treated), 2245 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 10.26 (P < 0.00001)
Total (95% CI) 6990 31218 100.0 % 1.71 [ 1.31, 2.22 ]
Total events: 852 (Treated), 2320 (Untreated)
Heterogeneity: Tau2 = 0.05; Chi2 = 11.94, df = 7 (P = 0.10); I2 =41%
Test for overall effect: Z = 3.99 (P = 0.000067)
Test for subgroup differences: Chi2 = 0.59, df = 2 (P = 0.74), I2 =0.0%
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Analysis 2.9. Comparison 2 Early pregnancy outcomes, Outcome 9 Termination of pregnancy rates
(treatment versus no treatment).
Review: Fertility and early pregnancy outcomes after conservative treatment for cervical intraepithelial neoplasia
Comparison: 2 Early pregnancy outcomes
Outcome: 9 Termination of pregnancy rates (treatment versus no treatment)
Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
1 CKC versus no treatment
Buller 1982 24/88 15/106 13.4 % 1.93 [ 1.08, 3.44 ]
Larsson 1982 47/294 19/341 15.8 % 2.87 [ 1.72, 4.78 ]
Weber 1979 5/66 1/55 1.5 % 4.17 [ 0.50, 34.61 ]
Subtotal (95% CI) 448 502 30.7 % 2.45 [ 1.68, 3.58 ]
Total events: 76 (Treated), 35 (Untreated)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.27, df = 2 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 4.67 (P < 0.00001)
2 LLETZ/LEEP versus no treatment
Turlington 1996 0/15 2/21 0.8 % 0.28 [ 0.01, 5.35 ]
Subtotal (95% CI) 15 21 0.8 % 0.28 [ 0.01, 5.35 ]
Total events: 0 (Treated), 2 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 0.85 (P = 0.39)
3 Laser conisation versus no treatment
Sagot 1995 6/71 10/82 6.3 % 0.69 [ 0.27, 1.81 ]
Spitzer 1995 23/67 4/28 6.2 % 2.40 [ 0.91, 6.31 ]
Subtotal (95% CI) 138 110 12.5 % 1.29 [ 0.38, 4.36 ]
Total events: 29 (Treated), 14 (Untreated)
Heterogeneity: Tau2 = 0.53; Chi2 = 3.20, df = 1 (P = 0.07); I2 =69%
Test for overall effect: Z = 0.41 (P = 0.68)
4 Laser ablation versus no treatment
Spitzer 1995 52/210 24/149 18.8 % 1.54 [ 0.99, 2.38 ]
Subtotal (95% CI) 210 149 18.8 % 1.54 [ 0.99, 2.38 ]
Total events: 52 (Treated), 24 (Untreated)
Heterogeneity: not applicable
Test for overall effect: Z = 1.93 (P = 0.053)
5 Treatment not specified versus no treatment
Kallialla 2012 695/6179 2245/30436 37.3 % 1.52 [ 1.41, 1.65 ]
Subtotal (95% CI) 6179 30436 37.3 % 1.52 [ 1.41, 1.65 ]
Total events: 695 (Treated), 2245 (Untreated)
Heterogeneity: not applicable
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Study or subgroup Treated Untreated Risk Ratio Weight Risk Ratio
n/N n/N IV,Random,95% CI IV,Random,95% CI
Test for overall effect: Z = 10.26 (P < 0.00001)
Total (95% CI) 6990 31218 100.0 % 1.71 [ 1.31, 2.22 ]
Total events: 852 (Treated), 2320 (Untreated)
Heterogeneity: Tau2 = 0.05; Chi2 = 11.94, df = 7 (P = 0.10); I2 =41%
Test for overall effect: Z = 3.99 (P = 0.000067)
Test for subgroup differences: Chi2 = 7.27, df = 4 (P = 0.12), I2 =45%
0.01 0.1 1 10 100
Favours untreated group Favours treated group
A P P E N D I C E S
Appendix 1. MEDLINE Search Strategy
1 exp Uterine Cervical Neoplasms/
2 (cervi* and (cancer* or tumor* or tumour* or neoplas* or malignan* or carcinom*)).mp.
3 exp Cervical Intraepithelial Neoplasia/
4 CIN.mp.
5 (cervi* and (intraepithel* or epithel* or dysplasia or pre-cancer* or precancer*)).mp.
6 or/1-5
7 exp Conization/
8 (conisation or conization).mp.
9 exp Laser Therapy/
10 laser.mp.
11 exp Cryotherapy/
12 cryotherapy.mp.
13 cold coagulation.mp.
14 exp Diathermy/
15 diatherm*.mp.
16 cone biopsy.mp.
17 loop.mp.
18 LLETZ.mp.
19 LEEP.mp.
20 ablat*.mp.
21 excision*.mp.
22 transformation zone.mp.
23 (CKC or LA or LC or CC or RD or TZ).mp.
24 (conservative and (method* or treatment* or intervention* or management)).mp.
25 or/7-24
26 6 and 25
27 exp Premature Birth/
28 (preterm or premature).mp.
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29 exp Infant, Low Birth Weight/
30 birth weight.mp.
31 Perinatal Mortality/
32 perinatal mortality.mp.
33 exp Intensive Care, Neonatal/
34 (neonatal and intensive care).mp.
35 exp Fertility/
36 fertil*.mp.
37 conception.mp.
38 exp Pregnancy/
39 pregnancy.mp.
40 gestation*.mp.
41 exp Abortion, Spontaneous/
42 miscarriage*.mp.
43 exp Cesarean Section/
44 (cesarean or caesarean).mp.
45 exp Obstetric Labor, Premature/
46 exp Labor, Obstetric/
47 (labor or labour).mp.
48 Fetal Membranes, Premature Rupture/
49 pPROM.mp.
50 or/27-49
51 26 and 50
key:
mp=title, original title, abstract, name of substance word, subject heading word
Appendix 2. EMBASE Search Strategy
1 exp uterine cervix tumor/
2 (cervi* and (cancer* or tumor* or tumour* or neoplas* or malignan* or carcinom*)).mp.
3 uterine cervix carcinoma in situ/
4 CIN.mp.
5 (cervi* and (intraepithel* or epithel* or dysplasia or pre-cancer* or precancer*)).mp.
6 or/1-5
7 uterine cervix conization/
8 (conisation or conization).mp.
9 low level laser therapy/
10 laser.mp.
11 exp cryotherapy/
12 cryotherapy.mp.
13 cold coagulation.mp.
14 diathermy/
15 diatherm*.mp.
16 cone biopsy.mp.
17 loop.mp.
18 LLETZ.mp.
19 LEEP.mp.
20 ablat*.mp.
21 excision*.mp.
22 transformation zone.mp.
23 (CKC or LA or LC or CC or RD or TZ).mp.
24 (conservative and (method* or treatment* or intervention* or management)).mp.
25 or/7-24
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26 6 and 25
27 prematurity/
28 (preterm or premature).mp.
29 exp low birth weight/~
30 birth weight.mp.
31 perinatal mortality/
32 perinatal mortality.mp.
33 newborn intensive care/
34 (neonat* and intensive care).mp.
35 female fertility/
36 fertil*.mp.
37 conception/
38 conception.mp.
39 exp pregnancy/
40 pregnancy.mp.
41 gestation*.mp.
42 spontaneous abortion/
43 miscarriage*.mp.
44 cesarean section/
45 (cesarean or caesarean).mp.
46 premature labor/
47 (labor or labour).mp.
48 premature fetus membrane rupture/
49 pPROM.mp.
50 or/27-49
51 26 and 50
key:
mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufacturer name
Appendix 3. CENTRAL search strategy
#1 MeSH descriptor Uterine Cervical Neoplasms explode all trees
#2 cervi* and (cancer* or tumor* or tumour* or neoplas* or malignan* or carcinom*)
#3 MeSH descriptor Cervical Intraepithelial Neoplasia explode all trees
#4 CIN
#5 cervi* and (intraepithel* or epithel* or dysplasia or pre-cancer* or precancer*)
#6 (#1 OR #2 OR #3 OR #4 OR #5)
#7 MeSH descriptor Conization explode all trees
#8 conisation or conization
#9 MeSH descriptor Laser Therapy explode all trees
#10 laser
#11 MeSH descriptor Cryotherapy explode all trees
#12 cryotherapy
#13 cold coagulation
#14 MeSH descriptor Diathermy explode all trees
#15 diatherm*
#16 cone biopsy
#17 loop
#18 LLETZ
#19 LEEP
#20 ablat*
#21 excision*
#22 transformation zone
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#23 CKC or LA or LC or CC or RD or TZ
#24 conservative and (method* or treatment* or intervention* or management)
#25 (#7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21 OR
#22 OR #23 OR #24)
#26 (#6 AND #25)
#27 MeSH descriptor Premature Birth explode all trees
#28 preterm or premature
#29 MeSH descriptor Infant, Low Birth Weight explode all trees
#30 birth weight
#31 MeSH descriptor Perinatal Mortality explode all trees
#32 perinatal mortality
#33 MeSH descriptor Intensive Care, Neonatal explode all trees
#34 neonat* and (intensive care)
#35 MeSH descriptor Fertility explode all trees
#36 fertil*
#37 conception
#38 MeSH descriptor Pregnancy explode all trees
#39 pregnancy
#40 gestation*
#41 MeSH descriptor Abortion, Spontaneous explode all trees
#42 miscarriage*
#43 MeSH descriptor Cesarean Section explode all trees
#44 cesarean or caesarean
#45 MeSH descriptor Obstetric Labor, Premature explode all trees
#46 MeSH descriptor Labor, Obstetric explode all trees
#47 labor or labour
#48 MeSH descriptor Fetal Membranes, Premature Rupture explode all trees
#49 pPROM
#50 (#27 OR #28 OR #29 OR #30 OR #31 OR #32 OR #33 OR #34 OR #35 OR #36 OR #37 OR #38 OR #39 OR #40 OR #41
OR #42 OR #43 OR #44 OR #45 OR #46 OR #47 OR #48 OR #49)
#51 (#26 AND #50)
Appendix 4. Newcastle-Ottawa score
Reference Score Selection Compara-
bility
Outcome
Represen-
tativeness
of the ex-
posed co-
hort
Se-
lection of
the non ex-
posed co-
hort
Ascertain-
ment of ex-
posure
Demon-
stration
that out-
come of in-
ter-
est was not
present
at start of
study
Compa-
rability of
cohorts on
the basis of
the design
or analysis
Assess-
ment of
outcome
Was
follow-up
long
enough for
outcomes
to occur
Ad-
equacy of
follow up
of cohorts
Weber
1979
8 *Some-
what repre-
sentative
*Drawn
from the
same com-
*Hospital
records
*Yes *Match-
ing for age
*Record
linkage
*Yes * Complete
follow-up
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(Continued)
of the aver-
age women
with CIN
in the com-
munity
munity as
the exposed
cohort
or internal
matching
- retrospec-
tive
Larsson
1982
9 *Truly rep-
resentative
of the aver-
age women
with CIN
in the com-
munity
*Internal
matching
*National
registry
*Yes **Inter-
nal match-
ing & also
matching
for age, par-
ity, socio-
economic
status and
smoking
*Record
linkage
*Yes * Complete
follow-up
- retrospec-
tive
Buller
1982
7 *Some-
what repre-
sentative
of the aver-
age women
with CIN
in the com-
munity
*Internal
matching
*Hospital
records
*Yes *Internal
matching
*Record
linkage
*Yes Inade-
quate: 27%
lost to fol-
low-
up - no de-
scription of
those lost
Blomfield
1993
9 *Some-
what repre-
sentative
of the aver-
age women
with CIN
in the com-
munity
*Drawn
from the
same com-
munity as
the exposed
cohort
*Hospital
records
*Yes **Match-
ing for age,
parity, eth-
nicity
*Record
linkage
*Yes * Complete
follow-up
- retrospec-
tive
Bigrigg
1994
7 *Some-
what repre-
sentative
of the aver-
age women
with CIN
in the com-
munity
*Drawn
from the
same com-
munity as
the exposed
cohort
*Hospital
records
*Yes **Match-
ing
for age and
geographic
area. Con-
trols
had a nega-
tive smear
Self-
reporting
*Yes Inad-
equate: 24.
2% lost to
follow-
up - no de-
scription of
those lost
Cruick-
shank
1995
7 *Some-
what repre-
sentative
of the aver-
age women
with CIN
*Drawn
from the
same com-
munity as
the exposed
cohort
*Hospital
records
*Yes **Match-
ing for age,
par-
ity, height
smoking
and
Self-
reporting
*Yes Inad-
equate: 34.
7% did not
respond to
question-
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(Continued)
in the com-
munity
partners so-
cial class
naire - no
de-
scription of
those lost
Sagot 1995 7 *Some-
what repre-
sentative
of the aver-
age women
with CIN
in the com-
munity
*Internal
matching
*Hospital
records
*Yes *Internal
matching
*Record
linkage
*Yes Inad-
equate: 21.
6% did not
respond to
question-
naire - no
de-
scription of
those lost
Spitzer
1995
7 *Some-
what repre-
sentative
of the aver-
age women
with CIN
in the com-
munity
*Internal
matching
*Hospital
records
*Yes **Internal
matched
for age and
par-
ity with the
pre-treat-
ment inter-
val
of the same
patients
Self-
reporting
*Yes Inad-
equate: 47.
9% did not
respond to
question-
naire - no
de-
scription of
those lost
Turlington
1996
7 *Some-
what repre-
sentative
of the aver-
age women
with CIN
in the com-
munity
*Drawn
from the
same com-
munity as
the exposed
cohort
*Hospital
records
*Yes *Un-
matched
- had col-
poscopy +/
-biopsy but
no
treatment
Self-
reporting
*Yes Inad-
equate: 29.
7% did not
re-
ply to ques-
tionnaire
Tan 2004 9 *Some-
what repre-
sentative
of the aver-
age women
with CIN
in the com-
munity
*Drawn
from the
same com-
munity as
the exposed
cohort
*Hospital
records
*Yes **Match-
ing for age
and parity
*Record
linkage
*Yes Inade-
quate: in
29.2% in-
complete
retrieval of
data
Sjoborg
2007
8 *Some-
what repre-
sentative
of the aver-
age women
*Drawn
from the
same com-
munity as
the exposed
*Hospital
records
*Yes **Match-
ing for age,
parity, plu-
rality and
regression
*Record
linkage
*Yes Inade-
quate: 69%
of
the women
did not give
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(Continued)
with CIN
in the com-
munity
cohort analysis for
smoking,
marital sta-
tus and ed-
ucation
their
consent
Albrechte-
sen 2008
9 *Truly rep-
resentative
of the aver-
age women
with CIN
in the com-
munity
*Drawn
from the
same com-
munity as
the exposed
cohort
*National
registry
*Yes **Regres-
sion analy-
sis
for age and
birth order
*Record
linkage
*Yes * Complete
follow-up
- retrospec-
tive
Kalliala
2012
9 *Truly rep-
resentative
of the aver-
age women
with CIN
in the com-
munity
*Drawn
from the
same com-
munity as
the exposed
cohort
*National
registry and
hospital
records
*Yes **Regres-
sion analy-
sis for num-
ber of preg-
nancies and
children,
age, munic-
ipality
*Record
linkage
*Yes * Complete
follow-up
- retrospec-
tive
Frega 2013 9 *Some-
what repre-
sentative
of the aver-
age women
with CIN
in the com-
munity
*Drawn
from the
same com-
munity as
the exposed
cohort
* Hospital
records
*Yes **Women
of same age
group, eth-
nicity, nul-
li-
parous, that
had sponta-
neous preg-
nancy
*Record
linkage
*Yes *Sub-
jects lost to
follow up
< 5% un-
likely to in-
troduce
bias
Spracklen
2013
8 *Some-
what repre-
sentative
of the aver-
age women
with CIN
in the com-
munity
*Drawn
from the
same com-
munity as
the exposed
cohort
*Compute-
as-
sisted struc-
tured tele-
phone
interview
*Yes ** Regres-
sion analy-
sis for age,
education,
household
in-
come, race,
parity, pre-
pregnancy
BMI,
smoking
and a group
of women
attending
colposcopy
Self-
reporting
*Yes Inad-
equate: 52.
6% of the
women did
not reply or
did not give
their
consent
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(Continued)
without
treatment
Appendix 5. List of abbreviations
CENTRAL: Cochrane Central Register of Controlled Trials
CKC: cold knife conisation
CI: (95%) confidence interval
CIN: cervical intraepithelial neoplasia
CC: cold coagulation
CT: cryotherapy
LA: laser ablation
LC: laser conisation
LEEP: loop electrosurgical excision procedure
LLETZ: large loop excision of the transformation zone
NE: not estimable
NETZ: needle excision of the transformation zone
NOS: not otherwise specified
RCT: randomised controlled trial
RD: radical diathermy
RR: relative risk
SWETZ: straight wire excision of the transformation zone
TOP: Termination of pregnancy
TZ: transformation zone
Appendix 6. List of definitions
First trimester miscarriage: miscarriage less than 12 weeks of gestation
Second trimester miscarriage: miscarriage between 13 and 24 weeks of gestation
WH A T ’ S N E W
Last assessed as up-to-date: 5 January 2015.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
The original protocol was drafted to analyse fertility, early pregnancy and obstetric outcomes in women with a history of treatment
for CIN versus untreated controls. Due to the clinical difference of the outcomes and the large number of studies, interventions and
outcomes, it was decided to split the review into two. This review addresses the impact of treatment on fertility and early pregnancy
outcomes and the second review will address obstetric outcomes. The type of participants section is altered to reflect the focus of this
review which is fertility and early pregnancy outcomes after the original protocol was split. We also included a treatment technique
called NETZ or SWETZ as they are a variation of LLETZ/LEEP.
We intended to assess the risk of publication bias (Steichen 1998), the analysis for small study effects and other potential sources of
heterogeneity for each individual meta-analysis, however due to the small number of studies this could not be formally assessed.
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